Medical News & Insights

Global and Chinese healthcare advancements at your fingertips

All News International China Medical Medical Breakthroughs
News Cover
WHO июл 19, 2026

Road deaths fall by 21% globally but stronger action is needed to save lives

Despite the addition of more than one billion motor-vehicles to the world’s roads, road traffic deaths declined by 21% between 2011 and 2025, according to new data released by the World Health Organization (WHO). The world has experienced profound changes in road traffic during this time with the emergence of new modes of transport and a sharp rise in motorcycle use. Despite this progress, however, road traffic crashes still claimed 1.16 million people's lives in 2025. Road traffic injuries remain the leading cause of death among children and youth aged 5–29 years. The new WHO data comes as global leaders today adopt a new United Nations (UN) General Assembly progress declaration on road safety. The declaration aims to boost global action to meet the Sustainable Development Goal (SDG) target of a 50% reduction in road deaths and serious injuries by 2030 compared with the levels in 2021.“This progress shows that change is possible when countries invest in safe road systems. In the last 15 years we’ve made real progress in reducing road deaths, despite surging vehicle numbers and major shifts in how people move,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “I commend countries for the strong political declaration they are adopting today, which aims to accelerate action to ensure more roads are designed for people first, not motor vehicles, with safety as priority. All road deaths are preventable and none are acceptable.”The new UN declaration includes a comprehensive set of commitments by UN Member States to implement national road safety strategies with clear targets, timelines and budgets. These commitments include establishing lead road safety agencies, improving data collection and analysis, developing and enforcing stronger legislation, and ensuring that roads, infrastructure and vehicles meet key safety standards.The declaration commits countries to implementing the proven ‘safe system’ approach, which recognizes that people will always make mistakes on the road. The approach promotes safer roads, infrastructure, vehicles, speed limits and regulations that account for human error and ensure that crash impacts remain within survivable levels. It also calls on governments to provide leadership and take additional action, and urges the private sector to prioritize road safety throughout their supply chains. The declaration also highlights the important roles of civil society, academia, youth, philanthropic organizations and the UN in driving progress.Safer roads for a safer futureWith nearly 60% of the world’s population now living in urban areas, growing demand for mobility threatens to overwhelm transport systems that were largely designed around private motor vehicles.With the rise of ride-hailing and delivery apps, the number of motorcycles more than tripled between 2011 and 2025. Deaths among motorcyclists now account for nearly a third of the world’s road fatalities. Wearing a safe motorcycle helmet reduces the risk of death in a crash by more than six times. New forms of mobility, including e-scooters, e-bikes and autonomous vehicles, present both challenges and opportunities for transport planners and policy-makers. WHO is working to close gaps in laws and rules, promote consistent safety standards and is bringing together leading experts to find new ways to ensure all new vehicles and technologies are safe. “More than half of all road deaths are people who aren't even in a car – they are walking, cycling or riding a motorcycle. When roads are designed as if only car drivers matter, these people are left dangerously exposed,” said Dr Etienne Krug Director of the Department of Health Determinants, Promotion and Prevention at WHO. “We know what works –  strong laws and enforcement, safe infrastructure and vehicles with particular attention to lowering speed and addressing impaired driving. This declaration means we must all go further and faster.” Across the world, 10 countries reduced road deaths by 50% in the decade to 2021 and more than half of all countries reported falling fatalities in that period. Yet progress is uneven, with 36% drop in deaths in the WHO European Region, a 15% drop in the Western Pacific Region, a 2% drop in the WHO South-East Asian Region, no change in rates in the Americas and a 17% rise in deaths in the WHO African Region.  The new UN declaration states that strengthening road safety is key to improving public health and sustainable development overall. More people choosing to walk, cycle and use public transport can reduce congestion, improving air quality, create more livable cities, and support healthier, longer lives.

Read full article →
News Cover
WHO июл 15, 2026

New WHO guidelines: up to 45% of dementia risk could be prevented or delayed

The World Health Organization (WHO) today released updated guidelines on reducing the risk of cognitive decline and dementia, providing countries with evidence-based recommendations to help prevent or delay the onset of dementia across the life course. Dementia is a condition caused by brain diseases and affects memory, thinking and the ability to function. More than 57 million people live with dementia worldwide and nearly 10 million people get newly diagnosed every year. Alzheimer disease is the most common form of dementia and is estimated to account for 60–70% of cases.While there is no cure for dementia, up to 45% of the risks can be attributed to modifiable risk factors such as tobacco, alcohol use, social isolation, physical inactivity, air pollution and noncommunicable diseases (NCDs), including high blood pressure and diabetes. Beyond health, dementia affects a person’s independence, dignity and safety. "We know more today than ever before about what drives dementia risk, and these guidelines translate that knowledge into action," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "Countries now have clear, evidence-based recommendations they can put into practice immediately to protect people's cognitive health."WHO’s new guidelines reflect the latest evidence and innovations in dementia risk reduction providing proven interventions that can effectively lower dementia risk through early awareness and timely action. They represent an important opportunity to reduce the burden of dementia in the coming decades through stronger integration of services for noncommunicable diseases, mental health and brain health.Reducing risk, preventing illnessThe updated guidelines reflect significant growth in the evidence base since WHO first issued recommendations on dementia risk reduction in 2019. They provide consolidated recommendations on addressing unhealthy behaviours, managing medical conditions, and reducing exposure to environmental factors that may contribute to cognitive decline and dementia.The guidelines recommend several healthy behaviours and lifestyle interventions to reduce dementia risk, including cognitive training and cognitive stimulation and engagement in social activities for adults who have normal cognition or are experiencing mild cognitive impairment.The updated advice also includes interventions that reduce risk of NCDs, including increasing physical activity, stopping tobacco use, reducing alcohol consumption, adopting a healthy diet, and a new recommendation to reduce exposure to air pollution. Management of cardiometabolic conditions such as hypertension, diabetes, and high cholesterol can also help reduce dementia risk. Further, hearing aids may be offered as part of risk-reduction strategies.As an intervention to reduce the risk of cognitive decline and/or dementia, the guidelines do not recommend supplementation with vitamins B and E, omega-3 polyunsaturated fatty acids (PUFA) and multivitamins/minerals in the absence of a diagnosed deficiency, due to the lack of evidence of any potential benefits to outweigh unexpected harmful effects.  Human and economic costDementia affects an individual’s ability to live independently, work and function, while placing substantial burdens on families and carers. It carries a major economic loss, costing the global economy an estimated US$ 1.3 trillion annually. About half of this cost is driven by unpaid care provided by families and friends. Understanding risk factors and taking action to prevent dementia can improve health and quality of life, helping people live longer, healthier and more independent lives.

Read full article →
News Cover
WHO июл 14, 2026

Global childhood immunization coverage inches forward despite conflict and hesitancy – UNICEF, WHO

In 2025, 90% of infants globally – or nearly 116 million – received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine, and 85% – or 110 million – completed the full three-dose series, according to the annual WHO-UNICEF Estimates of National Immunization Coverage (WUENIC) released today.  While both indicators rose by one percentage point from the previous year, global coverage remains one point below 2019 levels – hovering within the same narrow range since 2009. According to the data, an estimated 13.5 million “zero-dose” children did not receive a single vaccine in their first year during 2025. While these represent nearly 750 000 fewer children than the previous year, progress is offset by a rising number of children who start the schedule and do not complete it. Most of these children live in countries where national immunization programmes receive support from Gavi, the Vaccine Alliance. Globally, 7.3 million infants are estimated to have received their first DTP dose but dropped out before receiving their first measles dose. This drop-out rate contributed to stalled measles coverage with 84% of children receiving the first measles dose (MCV1) and 77% receiving the second dose (MCV2). Both figures fall far short of the 95% threshold required to prevent outbreaks of this highly contagious virus. Consequently, 57 countries reported large or disruptive measles outbreaks in 2025. “Governments and health workers have helped global vaccination rates bounce back after dropping significantly during the COVID-19 pandemic," said UNICEF Executive Director Catherine Russell. "But millions of vulnerable children are still being left unprotected due to conflict, displacement, and poverty.  We must reach every child, and we must rebuild trust where it is fraying. No child should suffer from a disease that a simple vaccine can prevent.” Data from 195 countries show that 100 countries have maintained at least 90% coverage with three doses of DTP vaccine since 2019, with little progress in expanding this group. Of the countries below 90% coverage in 2019, 30 improved their rates over the past six years, but 65 countries are stagnating or falling behind, including 13 fragile, conflict-affected or vulnerable countries (FCV).Compared to their 2019 baselines, the Americas and South-East Asia have fully recovered and improved their performance, with the latter now the highest performing region. While Africa, the Eastern Mediterranean, and Europe regions saw gains last year, their coverage remains below pre-COVID-19 pandemic levels. By contrast, the Western Pacific experienced a decline, leaving it the region furthest below its 2019 baseline.Behind these global and regional averages are persistent threats that are driving variability and volatility in country-level vaccination coverage.More than half of all zero-dose children live in FCV settings, even though they account for only about a third of the world’s child population. In these settings, immunization programmes are often strained by political upheaval, insecurity, or chronic underfunding. For example, in a single year, Syria lost 6 percentage points on DTP1 coverage and 12 points on MCV1. However, Sudan recorded the largest single-country gain globally last year, increasing DTP1 coverage by 35 percentage points and lifting MCV1 coverage by 22 points, demonstrating what is possible when access to services improves even amid ongoing conflict.In middle- and high‑income countries, even where vaccines are fully accessible, coverage is slipping amid shifting political commitment, structural challenges or rising hesitancy. For example, South Africa's DTP1 coverage has fallen 20 percentage points since 2019 and continued to decline in 2025. After the largest increase in MCV1 coverage in the region in 2024, Bosnia and Herzegovina saw a 23-point drop in the past year.“Every child, whether born into wealth or poverty, peace or conflict, deserves the lifegiving protection that vaccines provide. Immunization is one of the most cost-effective, most equitable, and most reliable interventions for protecting children’s health and well-being,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Our greatest security begins with ensuring that everyone, wherever they may live, is protected from deadly diseases that vaccines have the power to prevent.” Over the past 25 years, sustained investments from governments and partners, commitments from communities, strengthened programmes, and broad public trust have reduced the annual number of zero-dose children by 40%. For example, in countries supported by Gavi, children today are protected against more diseases than ever before, with 74% average coverage today across a full course of WHO-recommended vaccines. “The historic levels of immunization that we are seeing across lower income countries shows what can be achieved when all stakeholders work together towards a shared objective,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “As Gavi heads into a new five-year period, our great challenge now will be to maintain this momentum in the face of funding constraints, geopolitical uncertainty, and increasing outbreaks – while working harder to reach those children that still do not have access to immunization.”  However, the foundations that enabled progress are now under significant strain. The full impact of cuts to international health financing announced over the past two years is not yet reflected in these estimates, but the data systems needed to track that impact and protect against backsliding are themselves showing strain. According to the data, only 18 national immunization surveys were undertaken and submitted this round, down from 50 in 2024 and an average of 33 per year between 2015 and 2019. Weakening investments in the data systems needed to find and reach children who are missing out on vaccines will lead to outbreaks and deaths that could have been prevented, warn the agencies.  WHO and UNICEF are working with Gavi, the Vaccine Alliance and other partners to deliver the global Immunization Agenda 2030 (IA2030) goal to ensure vaccines reach everyone, everywhere, at every age, yet the world is further off track to reach the global target of reducing zero-dose children.To make this sharp course correction and bridge the critical gap, WHO and UNICEF call on governments and relevant partners to: strengthen immunization in conflict and fragile settings to reach and retain children;counter false and misleading health information and fully support vaccine uptake acceleration; increase and sustain domestic and global funding for immunization programmes and partnerships, including Gavi; andinvest in stronger data and disease surveillance systems to drive and guide high-impact immunization programme strengthening efforts. Notes to editors: Download multimedia content here.Access the WHO dataset: Global dashboard, country profiles, and additional resources  Access the UNICEF dataset: Overview page, Full datasets, Data visualisation, Regional data visualisation, Country profiles  WUENIC estimates, including historical data, are revised annually as new country data become available. Figures in this release should not be compared against previous years' published reports. Based on country-reported data, the WHO and UNICEF estimates of national immunization coverage (WUENIC) provide the world’s largest and most comprehensive dataset on immunization trends for vaccinations against 13 diseases given through regular health systems  – normally at clinics, community centres, outreach services, or health worker visits. For 2025 data were provided from 185 countries. WHO and UNICEF are working with Gavi, the Vaccine Alliance and other partners to deliver the global Immunization Agenda 2030 (IA2030), a strategy for all countries and relevant global partners to achieve set goals on preventing diseases through immunization and delivering vaccines to everyone, everywhere, at every age.About UNICEF UNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential. For more information about UNICEF and its work, please visit: www.unicef.org  About WHO Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the United Nations’ agency for health that connects nations, partners and people in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to support all countries to promote, provide and protect health. “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO июл 02, 2026

WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately.WHO’s EUL procedure assesses the quality, safety and performance of essential health products based on the available evidence, while ensuring they meet minimum international standards and address the needs of low- and middle-income countries.Through this mechanism, WHO aims to accelerate access to reliable diagnostic tools for early case detection, timely clinical care, disease surveillance and effective outbreak response. The EUL also supports United Nations procurement agencies and governments in making informed decisions about the procurement and use of these products in public health emergency settings."Public health emergencies require not only speed, but also confidence that the health products being used meet standards for quality, safety and performance," said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. "During a fast-moving outbreak, timely access to quality-assured diagnostic tests can make a critical difference in containing transmission. Through this Emergency Use Listing, WHO is helping countries access trusted diagnostic tools more rapidly so that they can respond more effectively.”On 17 May 2026, WHO Director-General Dr Tedros Adhanom Ghebreyesus declared a public health emergency of international concern over the outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo, with cases in Uganda. Less than two weeks later, WHO launched a call for manufacturers of IVDs for Bundibugyo virus to submit Expressions of Interest for Emergency Use Listing.The listing comes at a critical time as countries respond to the largest recorded outbreak of Ebola disease caused by BDBV, which continues to expand. As of today, 1406 laboratory-confirmed cases and 438 deaths had been reported in the Democratic Republic of the Congo alone.With support from WHO and the Africa Centres for Disease Control and Prevention (Africa CDC), laboratory testing capacity has expanded from a limited number of sites – primarily Institut National de Recherche Biomédicale in Kinshasa and Goma, with an estimated combined capacity of approximately 200–400 tests per day – to a broader network of 10 laboratories across affected provinces, with a reported capacity of over 2000 tests per day. Rapid and reliable diagnosis remains essential to identify cases early, guide timely patient care, interruptand help bring outbreaks under control.WHO continues to work closely with manufacturers, global partners and countries to expand the availability of and access to safe, effective and quality-assured life-saving health products. Additional applications for BDBV IVDs submitted through the EUL procedure are currently under review.In parallel, WHO and Africa CDC, with partners including PATH, FIND and CHAI, and with support from Unitaid, are establishing a joint validation platform to rapidly evaluate the performance of a selection of diagnostic products, including laboratory-based molecular tests, near-point-of-care molecular tests and antigen rapid diagnostic tests. The platform will generate critically needed clinical evidence on the performance of these products in outbreak settings.Bundibugyo virus disease is a severe, often life-threatening disease caused by BDBV, one of three Ebola virus species known to cause large outbreaks in humans. The virus can spread from animals to humans and then from person to person through contact with a person sick or deceased and their infected bodily fluids or surfaces or items contaminated by these fluids.Information on active EUL applications for IVDs for BDBV nucleic acid detection can be found on these WHO webpages.About WHODedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life.We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to support countries to promote, provide and protect health.“Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO июн 23, 2026

WHO urges scale up of newborn screening to improve early detection and care of birth defects

The World Health Organization (WHO) today calls on countries to expand newborn screening for birth defects, highlighting how early detection and treatment can save lives and reduce lifelong disability for millions of children.A new WHO report, Strengthening capacity for newborn screening, diagnosis and management of birth defects, identifies newborn screening as an important opportunity to accelerate progress in child survival.Many conditions can be successfully treated if identified early after birth. These include congenital hypothyroidism, sickle-cell disease, hearing impairment and some metabolic disorders. Yet millions of children are still diagnosed too late or never receive treatment at all.Worldwide, an estimated 8 million babies are born with a birth defect each year, and birth defects now account for almost 8% of all deaths among children under five. An estimated 90% of children born with serious birth defects live in low- and middle-income countries, where access to screening, diagnosis and treatment remains limited."No child should miss the chance for a healthy future because a congenital condition was not detected early enough," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "Around the world, countries are showing that newborn screening for one or more conditions can save lives, prevent disability, and give a newborn the best opportunity to fulfil her or his potential ."The gap between countries is stark: some countries screen all newborns for more than 50 conditions, while others are unable to screen for any. WHO encourages every country to begin newborn screening — starting with a priority condition in the country and progressively expanding as capacity grows.The report shows that birth defects account for a growing proportion of under-five deaths in many regions. Between 2000 and 2023, the proportion of under-five deaths attributable to birth defects increased from 1% to 4% in sub-Saharan Africa and from 3% to 11% in South Asia. Part of this shift reflects genuine progress in the reduction of deaths from infectious and other preventable causes.The WHO report aims to support ministries of health, especially in low- and middle-income countries, to prioritize conditions for newborn screening depending on the country context.It showcases countries across Africa, Asia and the Americas that are already demonstrating the successful integration of large-scale newborn screening programmes into routine health services:Argentina: Increased newborn screening coverage to nearly universal levels.Brazil: Expanded nationwide screening for multiple life-threatening conditions.Egypt:  The ‘newborn care pathway’ integrates universal newborn screening for hearing and congenital hypothyroidism into its primary health care services.India: The national programme has screened more than 28 million children over three years, identifying approximately 900,000 children with a birth defect and connecting them with diagnosis, treatment and support, including long term care and rehabilitation services through district early intervention centres.Philippines: A programme that began as a pilot in 24 hospitals now screens newborns for 29 conditions through more than 7000 facilities nationwide. All conditions screened for have diagnostic and management pathways within the national health system. Newborn screening is covered by national health insurance and mandated by law.Sri Lanka: Newborn screening is integrated into routine care and includes visible birth defects and congenital hypothyroidism. Around 80% of newborns are now screened for congenital hypothyroidism.Uganda: A state-led programme for sickle-cell disease in high burden areas identifies affected infants early and provides them with lifesaving treatment and long-term follow-up care.WHO is urging governments to integrate newborn screening, diagnosis and treatment into routine health services and universal health coverage programmes, beginning with conditions that are country priorities, and that can be effectively detected and feasibly managed within their health system.The report was informed by a global WHO consultation bringing together government representatives, technical experts, clinicians, researchers, professional associations, civil society organizations and families affected by birth defects to identify priorities for strengthening newborn screening, diagnosis and long-term care.About WHODedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the United Nations’ agency for health that connects nations, partners and people in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to support all countries to promote, provide and protect health.“Together for health. Stand with science”, the theme of World Health Day 2026, marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO июн 15, 2026

Open letter to leaders of G7, G20, BRICS and all nations on finalizing the WHO Pandemic Agreement’s Pathogen Access and Benefit Sharing annex

Dear Leaders of the G7, the G20, BRICS and of all nations,We write to you together, from Geneva and from Brasília, with one shared conviction: that the world must finish what it started, and that you can help it do so.We begin not with an institution or an annex, but with a memory the whole world shares. Not so long ago, our hospitals overflowed. Families said goodbye to the people they loved through glass, or by telephone, or not at all. Children lost grandparents. Doctors and nurses, exhausted beyond anything we had a right to ask of them, kept going anyway. Estimates from WHO and others put the lives lost at up to twenty million. Humanity promised itself, in the rawness of that grief, that it would not face such a day again unprepared.A little over a year ago, the world kept the first part of that promise. After the deadliest pandemic in a century, the nations of the world chose cooperation over division and adopted the WHO Pandemic Agreement to strengthen how countries can work together to prevent, prepare for, and respond to pandemics. In a divided world, that outcome was not to be taken for granted. It was an act of hope, and an act of faith in one another. We write to you now because that hope is not yet fulfilled, and because it lies within your hands to help fulfil it.One piece remains. To respond to future pandemics in time, countries must be able to quickly identify pathogens with pandemic potential and share their genetic information and material so scientists can develop tools: the tests, the treatments, the vaccines that decide who lives and who does not. The system that makes this possible, fairly and on equal footing, is the Pathogen Access and Benefit-Sharing annex. It is the last piece of the puzzle, not only for the Pandemic Agreement but for everything WHO and Member States have built from the hard lessons of COVID-19. Until it is finished, the Agreement cannot enter into force. The promise stays unkept.We will not pretend the road has been easy. When Member States closed their most recent session on the first of May, they had made real progress, but agreed that more time was needed. The hardest questions, including how the benefits of shared pathogens are defined and shared, how the system is governed, and how equity is guaranteed on equal footing, are difficult for a reason. They are the very questions that went unanswered last time, while people who could have been protected were not. The world is wrestling with them now precisely because they matter so much.Negotiators will meet again from 6 to 17 July. We believe in them, and we have seen their dedication up close. But we also know there are moments when good people, doing their best around a negotiating table, need their leaders to lift their eyes to the horizon. This is one of those moments, and it is yours.So we come to you, plainly, with three requests.First, political will at the highest level. The remaining issues will not be solved by technical effort alone. They need the clear signal that only a head of government can give: that finishing this annex is a national priority, and that your negotiators may reach for consensus with courage rather than caution. Solidarity is our best immunity, but solidarity has to be chosen, and it has to be chosen at the top. We know, too, that you may be asked if the Pandemic Agreement compromises state sovereignty. It does not, and the PABS annex, as an integral part of it, will not either. Article 22, paragraph 2 says so plainly: nothing in the Agreement gives WHO any authority to direct or alter a country’s laws or policies, or to require measures such as lockdowns, travel restrictions or vaccination mandates. Those decisions remain with sovereign states. So we ask you, concretely, to instruct your negotiators to come to the July session ready to conclude, and to give them the flexibility to close the remaining gaps and finalize the annex in this round.Second, a spirit of equity. The PABS system rests on a simple, fair bargain: those who share dangerous pathogens quickly must be able to trust that the vaccines and treatments born from that sharing will reach their own people too. Every one of us has a stake on both sides of it. When Brazil held the G20 presidency in 2024, it led the G20 to recognize, for the first time, inequality as a driver of pandemics. This is not charity, and it is not only conscience. It is also strategy: PABS exists to stop an outbreak at its source, and containing a threat where it begins is far cheaper, in lives and in resources, than fighting a pandemic once it has spread to every continent. A virus left to burn anywhere will, in time, find everyone. There is a further reason equity matters, one that governments and industries everywhere will grasp at once: predictability. Today the rules for accessing a pathogen and sharing what flows from it are improvised case by case, often mid-crisis. PABS replaces that with a single framework known in advance, stable rules that let laboratories and partners across the world move at the speed an outbreak demands. Legal certainty does not compete with equity; it makes equity work. We ask you to ensure the annex carries equity in its operational detail, not only in its preamble, so that access and benefit-sharing are guaranteed in practice.Third, a sense of urgency. The next pandemic will not wait for us. Scientists estimate there is close to a one in four chance of another pandemic within the coming decade, and the ground beneath our old assumptions is shifting. Climate change, changing land use and evolving agriculture are redrawing the map of where dangerous pathogens emerge; the comfortable belief that outbreaks begin only in distant places is no longer true, and future hotspots may arise in or near your own countries. At the same time, advances in biotechnology, matched unevenly by biosafety, raise the risk of accidental or deliberate release. None of these dangers respect a border. So we ask you to treat 17 July as a deadline, not a milestone, and to say so publicly, sending your negotiators, and the world, the unambiguous signal that this is the round in which the work is finished.And we already know the price of being unready. The last pandemic took lives on a staggering scale, with estimates from WHO and others putting the toll at up to twenty million, and the International Monetary Fund estimates it cost the world economy over thirteen trillion dollars in lost output, a loss borne in every nation, in shuttered businesses, broken supply chains and a generation of disrupted schooling. Against that, the investment in a system that catches an outbreak early is small. As we write these words, an Ebola outbreak is being fought across two countries, with no approved vaccine and no cure, by responders who are risking their own lives to protect strangers. That is not a distant abstraction. It is happening now. Every month this annex stays unfinished is a month the world is less ready than it could be, and people are less safe than they deserve to be.The nations of the world, together, have stood at every great turning point in the story of human health. Together we helped wipe smallpox from the earth. We pushed polio to the very edge of history. We turned back the tide of HIV, tuberculosis and malaria, and in doing so helped save more lives than any of us will ever be able to count. Finishing this Agreement is not a departure from that legacy. It is its natural next chapter, and it is within reach.We made a promise to the millions we lost, and to the families who carry their absence still. Let us be the generation that keeps that promise. Finalizing this Agreement, through a shared commitment to one another, is our collective promise to protect humanity. Let us keep it, together, and in time.With respect, and in the shared cause of protecting human life, Luiz Inácio Lula da SilvaPresidentFederative Republic of Brazil Dr Tedros Adhanom GhebreyesusDirector-GeneralWorld Health Organization 

Read full article →
News Cover
WHO июн 05, 2026

Africa CDC and WHO launch joint continental Ebola response plan

The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) today launched a joint continental preparedness and response plan on the ongoing Ebola outbreak caused by the Bundibugyo virus. The plan aims to raise US$ 518 million to support African countries together with partners to prepare for, rapidly detect and respond to the outbreak.The six-month plan, covering June to November 2026, brings together governments, partners and communities under a unified ‘One Response’ approach to strengthen outbreak response measures, including emergency coordination, disease surveillance, laboratory testing, infection prevention and control, clinical care, community engagement, research, logistics and support for essential health services.The plan complements national response plans launched by the Governments of the Democratic Republic of the Congo and Uganda.“The only way to beat this outbreak is through close partnership, working together under the leadership of the affected countries in one coordinated effort, guided by a simple principle: one plan, one budget, one team,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Containing Ebola depends on political commitment, sustained financing, and the trust and engagement of communities. This plan places communities at the centre, because without their participation, contact tracing falters, safe care is delayed, and transmission continues.”Dr Jean Kaseya, Director-General of Africa CDC, said: “Ebola moves fast. Africa must move faster. This joint plan gives the continent a clear path to act with speed and unity: to save lives, support the affected countries and protect neighbouring communities. With Member States, WHO and partners, Africa CDC is turning commitment into action and resources into response for the communities at risk.”The plan also focuses on protecting vulnerable populations, strengthening cross-border collaboration, and supporting countries to respond quickly to new cases. At a time when there are no licensed vaccines or therapeutics specifically approved for the Bundibugyo species of Ebola, the plan aims to strengthen health systems to ensure resilience even as countries respond to acute health emergencies.Implementation of preparedness and response activities is already underway across affected and at-risk countries. Furthermore, in 10 priority countries critical measures are being strengthened to enhance public health emergency preparedness and ensure early detection and swift response.The plan emphasizes the need to maintain support for other ongoing health emergencies, including mpox, cholera and measles, to prevent disruptions to critical response efforts and safeguard progress towards stronger, more resilient health systems.This coordinated effort comes as response operations accelerate in the Democratic Republic of the Congo, where authorities, with support from Africa CDC, WHO and partners, are ramping up efforts to curb the spread of the virus and end the outbreak.Africa CDC and WHO urge Member States to strengthen screening and public health measures at points of entry and enhance cross-border coordination and solidarity to support a timely, effective and evidence-based response to the outbreak.Through the joint preparedness and response plan, the continent is mobilising its collective expertise and resources to reinforce response measures, acting as one to control the outbreak and protect communities across the region. Its successful implementation will require strong political commitment, sustained investment and close collaboration among governments, health workers, communities and partners.Drawing on lessons learned from previous Ebola outbreaks and recent public health emergencies, the plan also provides a pathway to broadly strengthen Africa’s capacity to prevent, detect and respond to future health threats while protecting lives and livelihoods.About Africa CDCThe Africa Centres for Disease Control and Prevention (Africa CDC) is the public health agency of the African Union. As an autonomous institution, Africa CDC supports AU Member States to strengthen health systems, improve disease surveillance, and enhance emergency preparedness and response. Africa CDC works with Member States, Regional Economic Communities and partners to prevent, detect and respond quickly and effectively to disease threats and outbreaks across the continent.For more information, visit www.africacdc.org and follow Africa CDC on LinkedIn, X, Facebook and YouTube. About WHODedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life.We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO мая 31, 2026

Joint statement by the Government of the Democratic Republic of the Congo and WHO concerning the outbreak of Ebola disease caused by the Bundibugyo virus

The Government of the Democratic Republic of the Congo (DRC) and the World Health Organization (WHO) reaffirm their strong partnership and shared commitment to protect the health and well-being of the people of Ituri Province and the nation at large, following the joint mission to Bunia led by Dr Samuel Roger Kamba, Minister of Health, Mr. Patrick Muyaya Katembwe, Minister of Communication and Medias, and the visit of WHO Director-General Dr Tedros Adhanom Ghebreyesus. This high-level visit comes at a challenging time, as the country responds to an outbreak of Ebola disease caused by the Bundibugyo virus. The Ministry of Health reports a rapidly evolving situation, with cases and deaths notified in several health zones of Ituri, North Kivu and South Kivu. The Government, with support from WHO and partners, is intensifying surveillance, laboratory testing and patient care to interrupt transmission as quickly as possibleThe Government of the DRC is firmly leading a comprehensive national response, working closely with provincial authorities in Ituri and neighbouring provinces. WHO, alongside the broader United Nations system and health and humanitarian partners, is fully committed to supporting these efforts. Together, DRC authorities, WHO and partners are working to strengthen coordination, mobilize additional resources, and ensure that life-saving interventions reach affected communities quickly and equitablyCentral to this response is the recognition that communities are at the heart of the solution. Success will depend on the trust, engagement and leadership of local communities. National and provincial authorities, with support from WHO and partners, are intensifying dialogue with community leaders, women's groups, youth representatives, religious leaders and the private sector to better understand local concerns and co-develop solutions that are culturally appropriate and effective.While the Bundibugyo strain presents additional challenges, including the absence of a licensed vaccine or specific treatment, proven public health measures remain effective in slowing transmission and potential full recovery. The Ministry of Health, WHO and partners are working to rapidly undertake randomized control trials on candidate vaccines and treatments.Persistent challenges include early detection and isolation of cases, contact tracing, safe and dignified burials, robust infection prevention and control in health facilities, and strong community awareness. The Government and WHO call on all communities to continue adopting protective behaviours, including regular hand hygiene, early care seeking in health facilities, and sharing accurate information.The DRC brings unparalleled experience to this response, having successfully contained multiple previous Ebola outbreaks. This experience, combined with strong political leadership at the highest level of the State and renewed international solidarity, provides a firm foundation for bringing the current outbreak under control. Both parties emphasize that outbreak response must maintain primary health care and essential services and strengthen long-term health system resilience. Investments made today in laboratories, health workers, surveillance systems and essential services will leave a legacy for the people of Ituri and the DRC as a whole.We sincerely thank our international partners for the support already provided to response operations, and we encourage sustained solidarity to bring this outbreak under control. Cooperation between countries must also ensure that borders remain open, and that entry controls do not obstruct the flow of desperately needed medical supplies and personnel.Together, DRC authorities, WHO, Africa CDC and partners are working to strengthen coordination, mobilize additional resources, and ensure that life-saving interventions reach affected communities quickly and equitably.

Read full article →
News Cover
WHO мая 28, 2026

Message by the WHO Director-General to the people of the Democratic Republic of the Congo

To the people of DRC, especially to the people of Ituri Jambo kwenu wakahaji wa Ituri Mbote na bino, bato ya Ituri My name is Tedros, and I am the Director-General of the World Health Organization (WHO). But today, I am not writing to you as an official. I am writing to you as someone who knows your region, who has walked your streets, and who cares deeply about what happens to you and your families. I am writing because I want to be with you in these moments. And I want you to know that you are not alone. Ebola is not new to me personally. From 2018 to 2020, I came fourteen times to North Kivu, the epicentre of the outbreak at that time. Fourteen visits to Beni, Butembo, Katwa, Goma, and many other communities. During that outbreak, Ebola spread across North Kivu, South Kivu, and reached parts of Ituri as well. I was alongside families who had lost their loved ones. I met health workers risking their lives every day. I met community leaders, traditional healers, religious leaders and business leaders who refused to abandon their people. I saw men and women show extraordinary courage in the most difficult of circumstances. The people there, who saw me coming back again and again, wanted to give me a name that belonged to their community. They asked me whether I was the first, second, or third child of my parents. When I told them I was the firstborn, they gave me the name Dr. Paluku. I carry that name with pride. It is not just a name. It is a bond. It is a reminder that this work is not about titles or institutions. It is about people. It is about you. That outbreak was one of the most complex in history. It did not unfold in a stable, peaceful environment. It happened in the middle of armed conflict, with communities displaced, supply routes disrupted, and health workers operating under constant threat. People were fleeing violence while also trying to protect themselves and their families from a deadly disease. I remember being in Beni on more than one occasion while fighting was taking place on the outskirts of the city. We could hear it. And yet the health workers around me did not stop. They kept working. That kind of courage is something I will never forget. The challenges of that time are not so different from what you are facing today in Ituri. I understand that. I have seen it with my own eyes. Mistrust ran deep, and the security situation cost us precious time. Our health workers were attacked. Clinics were targeted. People who were only trying to save lives found themselves caught in the middle of a conflict they did not start. Lives were lost that we might have saved, and that weighs on me still. But I also witnessed something remarkable. When we listened, when communities felt respected and heard, things began to change. Trust grew slowly, then more quickly. People came forward. And together, we managed to contain the outbreak. We did it. The people of DRC did it. I will never forget that. Ebola is now back. This time, the outbreak is hitting Ituri province the hardest. More than 90% of all cases have been reported in Ituri province, with a small number of cases also reported in North Kivu and South Kivu. I know how frightening that is, and I know that the people of Ituri are bearing a burden that is not easy to carry. I know that many of you are exhausted. You are already carrying so much: malaria, hunger, insecurity, and the daily struggle to keep your families safe. And now Ebola. It is not fair, and I will not pretend otherwise. But I also want to say something else about Ituri, because this province deserves to be seen for more than its hardships. Ituri is a place of remarkable energy. It is a province of vibrant commerce, of entrepreneurial spirit, of communities that have refused to be defined by the conflicts around them. The markets of Bunia buzz with life. Traders, farmers, teachers, and young people building their futures against all odds. That spirit, that refusal to give up, is exactly what we need now. It is the foundation on which we will build our response. We do not come to Ituri with only medicine and expertise. We come to join a community that already knows how to fight for its survival. I want to say a special word to the young people of Ituri. You are growing up in circumstances that no young person should have to face. And yet what I see, again and again, is not despair but determination. You are the future of this province and this country. In this outbreak, you have a vital role to play. Talk to your friends and your families. Share what you know about Ebola. Help break the fear and the silence that allow this virus to spread. Your voice carries further than you know, and we need it now more than ever. And to the health workers of Ituri, I want to say this: you are seen, and you are not alone. Every day you go to work knowing the risks, and you go anyway. You do it for your patients, for your communities, for your families. You are the backbone of this response. Without you, none of this is possible. I know the conditions are hard. I know the resources are often not enough. I know that fear and exhaustion are real. Please know that WHO stands with you, that we are working to get you the support you need, and that your courage and dedication are known and deeply valued far beyond the borders of this province. I also know that the security situation in parts of this region remains very difficult. Conflict and displacement make everything harder, including reaching people who need care and keeping health workers safe. I want to be honest: this is one of our greatest challenges. We cannot do this work if those who are trying to help are prevented from doing so or put in danger. We are working closely with all relevant partners to ensure that the response can reach every community that needs it, and that no one is left behind because of where they live or what is happening around them. That is why today I am making a direct appeal to all warring parties in this region: please, declare a ceasefire. Even briefly. Even just enough to let health workers through. People are dying from Ebola who do not have to die. Children are sick. Families are suffering. No cause, no conflict, no grievance is worth condemning innocent people to death from a preventable disease. A ceasefire, even a temporary one, would save lives. I urge you, I implore you: give us the space to help the people who need it most. I also know that there is anger and mistrust in some communities, and I understand why. Trust must be earned, it cannot be assumed. We have not always done things correctly. But I promise you, we are here to learn as much as we are here to help. I need to be honest with you about something important. Most previous Ebola outbreaks in DRC were caused by a virus called Ebola Zaire, for which we have vaccines and treatments. This outbreak is caused by a different virus called Ebola Bundibugyo. There are currently no approved vaccines or treatments for it. This is serious, and you deserve to hear that plainly. But I also want you to know this: while there are no specific treatments for Bundibugyo, there is much we can do together to prevent the spread of this virus and save lives. Early supportive care in our treatment centers can make a real difference. If you or someone you know falls ill, please do not wait. Coming forward early can make the difference between life and death. And everything we do, we will do with you. We will listen to you, we will share information with you, and we are here to help. And for those we cannot save, we will mourn with you. We will help you grieve your lost loved ones with safe and dignified burials. We are working under the leadership of the Government of DRC, together with all relevant partners, united around one goal: to stop this outbreak and protect your communities. No one is working alone. No one is working at cross purposes. We are coordinated, we are committed, and we are here. That is why I am coming to Bunia. I will be there in person, alongside my colleagues, meeting your leaders, listening to your concerns, and doing everything in my power to help you. I will not be managing this from a comfortable office far away. This is the 17th Ebola outbreak in DRC. Together, you have overcome every single one before. That is not a small thing. That is a testament to the strength and resilience of your communities. I have seen that strength with my own eyes. My brothers and sisters of Ituri, I want you to know that the world is watching your courage. You are not forgotten. Together, we will overcome this outbreak, as you have overcome every challenge before. Your resilience is the light that guides us all. We will get through this one too. Not because of anyone, but because of you. Our teams are already on the ground, and they will stay for as long as necessary. And when this outbreak is over, we will not quietly disappear. We will not forget you. We will stay, and we will keep working with you to build health systems that protect every person in every community.I look forward to seeing you in Bunia soon. Until then, please know that you are in my thoughts.With respect and solidarity,PalukuTedrosTedros Adhanom GhebreyesusDirector-General, World Health Organization 

Read full article →
News Cover
WHO мая 20, 2026

Seventy-ninth World Health Assembly honours global champions advancing primary health care

Today, the World Health Assembly recognized individuals and institutions whose contributions to global health have gone far beyond the call of duty. Six laureates representing diverse backgrounds and contexts were honoured by the President of the Seventy-ninth World Health Assembly, Dr Víctor Elias Atallah Lajam of Dominican Republic, together with representatives of the foundations that have provided these prizes over the last 40 years, and WHO Director-General Dr Tedros Adhanom Ghebreyesus.The 2026 prizes celebrate the remarkable dedication of the six awardees to advancing primary health care, reducing inequities and bringing the goal of health for all closer to reality. Selected by WHO’s Executive Board in February 2026, the 2026 laureates reflect a shared commitment to improving health outcomes through scientific excellence, innovation and community outreach. Their work ranges from strengthening primary health care systems and advancing disease control to empowering communities and expanding access to essential services for the most vulnerable populations.This year marks 20 years since the passing of Dr LEE Jong-wook, WHO’s sixth Director-General, who passed away unexpectedly during the World Health Assembly in 2006. One of the prizes awarded today, the Dr LEE Jong-wook Memorial Prize for Public Health, honours his legacy and enduring contribution to global health.Winners of the 2026 public health prizesSasakawa Health PrizeThe Banconi Community Health Association (ASACOBA), MaliRecognized for its pioneering role in strengthening community-based primary health care and empowering underserved populations through locally driven health services.United Arab Emirates Health Foundation PrizeDr Worawit Tontiwattanasap, ThailandRecognized for transforming access to health services for rural, stateless and cross-border populations through outreach services, training and policy advocacy.State of Kuwait Health Promotion Foundation’s His Highness Sheikh Sabah Al-Ahmad Al-Jaber Al-Sabah Prize for the Promotion of Healthy AgeingProfessor Bruno Vellas, FranceRecognized for advancing and developing innovative, community-based approaches to care for older people.SingHealth, SingaporeRecognized for its integrated, cross-sectoral and community-centred strategies supporting healthy ageing and age-friendly environments.Dr LEE Jong-wook Memorial Prize for Public Health Professor Mohammad Abul Faiz, BangladeshRecognized for his lifelong contribution to public health, particularly in addressing diseases affecting rural, poor and marginalized populations.Nelson Mandela Award for Health PromotionDr Amr Mohamed Kandeel, EgyptRecognized for his leadership in building a resilient, prevention-oriented public health system integrating disease control, digital innovation and equity. About WHO public health prizes and awardsEvery year, during the World Health Assembly, public health prizes and awards are presented to individuals and institutions from around the world for their outstanding contributions to public health.Public health foundation prizes are awarded following nominations submitted by WHO Member States and former laureates. Selection panels composed of representatives of the prize foundations and WHO Executive Board Members review candidates and make recommendations. The WHO Executive Board designates the winners each year, and the awards are presented during a plenary session of the World Health Assembly.Over the past 15 years, more than 80 laureates from over 50 WHO Member States have received public health prizes. In 2026, nearly 100 nominations were submitted from across all six WHO regions, reflecting a significant increase in global engagement in recognizing public health excellence.About WHO Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable.“Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO мая 18, 2026

World Health Assembly opens in Geneva, Switzerland

The Seventy-ninth session of the World Health Assembly (WHA79) opened in Geneva, Switzerland today, with the election of Dr Víctor Elías Atallah Lajam of the Dominican Republic as the President of the Health Assembly.   The elected Vice-Presidents are Dr Mohamed Ali Al-Ghouj of Libya, Dr Assa Badiallo Touré of Mali, Mrs Katarzyna Drążek -Laskowska of Poland, Mrs Neesha Mehta of Nepal, and Mr Elias Kapavore of Papua New Guinea. Dr Timur Sultangaziyev of Kazakhstan and Dr Kwabena Mintah Akandoh of Ghana are the Chairs of the Committee A and Committee B, respectively. During the high-level welcome, H.E. Elisabeth Baume‑Schneider, Federal Councillor of the Swiss Confederation, addressed the Health Assembly on behalf of the host country, followed by remarks from H.E. John Dramani Mahama, President of Ghana and Special Guest of Honour.   Delegates also heard video messages from H.E. António Guterres, United Nations Secretary‑General, H.E. Ahmad Al Sharaa, President of the Syrian Arab Republic, and H.E. Mia Mottley, Prime Minister of Barbados. Dr Tedros Adhanom Ghebreyesus, WHO Director‑General, addressed the Assembly and then presented the Awards for Global Health to Dr Tore Godal, Dr Merceline Dahl-Regis, Dr Mike Ryan and Dr Heba El Sewedy, recognizing their lifetime achievements and exceptional contributions to improving the health and well-being of communities worldwide. Special Guest, H.E. Pedro Sanchez, Prime Minister of Spain, addressed the Assembly at the conclusion of the afternoon session in the Plenary.  

Read full article →
News Cover
WHO мая 18, 2026

Director-General presents Award for Global Health to four distinguished leaders

At the Seventy-ninth World Health Assembly in Geneva, WHO Director-General Dr Tedros Adhanom Ghebreyesus has presented four distinguished leaders with the Award for Global Health, recognizing their lifetime achievements and exceptional contributions to improving the health and well-being of communities worldwide.This year’s laureates are Dr Tore Godal, Dr Merceline Dahl-Regis, Dr Mike Ryan and Dr Heba El Sewedy. They were celebrated during the High-Level Welcome of the World Health Assembly (WHA), held this year under the theme “Reshaping global health: a shared responsibility.”Established in 2019, the Director-General’s Awards for Global Health recognize individuals whose leadership and commitment have delivered tangible improvements in health outcomes around the world.“I am honoured to present the Global Health Leaders Awards to four individuals who have made outstanding lifetime contributions to global health,” said Dr Tedros.  Dr Tore Godal was recognized for his transformative leadership in immunization and infectious diseases. Throughout his distinguished career, he played a pivotal role in elevating vaccines as a global development priority and helped establish major initiatives including Gavi, the Vaccine Alliance, Roll Back Malaria and CEPI, the Coalition for Epidemic Preparedness Innovations. He also played a pivotal role in the fight against neglected diseases when leading WHO’s Tropical Diseases Programme, and expanding work on leprosy and malaria. He helped expand community-based ivermectin distribution and onchocerciasis control efforts, which contributed to protecting large populations from river blindness. Dr Godal’s work has translated scientific research into large-scale public health action, protecting millions of lives.Dr Merceline Dahl-Regis was recognized for her lifelong commitment in expanding immunization and disease elimination in the Region of the Americas and beyond. Her contributions were instrumental in achieving the elimination of measles and rubella in the Americas – the first region in the world to reach this milestone. Her advocacy and support of the regional Dual Elimination Initiative also supported the elimination of mother-to-child transmission of syphilis and HIV in the Americas. Through research, community engagement and regional collaboration, she has advanced a holistic approach to health and development and had a profound impact on the lives of many people in the Americas and globally.Dr Mike Ryan was honoured for his leadership in strengthening global preparedness for and response to health emergencies. A founder of the Global Outbreak Alert and Response Network (GOARN), he has shaped international systems for detecting and responding to epidemics, and – when serving as the Executive Director of WHO’s Health Emergencies Programme – led operational responses to SARS, cholera, Ebola, polio and COVID-19. His leadership during major outbreaks and humanitarian crises working in some of the most challenging environments has demonstrated an unwavering commitment to protecting vulnerable communities and advancing global health security.Dr Heba Elsewedy received the award for her dedication to humanitarian action and social justice. Through the Ahl Masr Foundation, which she founded in 2013, she has pioneered comprehensive approaches to the prevention and treatment of trauma and burn injuries, while promoting awareness, dignity and the reintegration of survivors. Dr Heba Elsewedy's foundation has been instrumental in providing medical and psychological support to burn victims, as well as humanitarian aid to those affected by the Gaza conflict. Her work has transformed lives and stands as a model of compassionate, people-centred care, and a source of inspiration for many young public health advocates.From steering large-public health actions, to leading scientific innovations, engaging with communities and protecting people against emergencies and infectious diseases, the 2026 awardees reflect the diversity of approaches needed to achieve the highest possible level of health for all. Their achievements serve as a source of inspiration for current and future generations working for a healthier, safer and more equitable world for all. 

Read full article →
News Cover
WHO мая 09, 2026

Message by the WHO Director-General to the people of Tenerife regarding the hantavirus response

To the people of Tenerife,My name is Tedros, and I serve as the Director-General of the World Health Organization, the United Nations agency responsible for global public health. It is not common for me to write directly to the people of a single community, but today I feel it is not only appropriate, it is necessary.I want to speak to you directly, not through press releases or technical briefings, but as one human being to another, because you deserve that.I know you are worried. I know that when you hear the word “outbreak” and watch a ship sail toward your shores, memories surface that none of us have fully put to rest. The pain of 2020 is still real, and I do not dismiss it for a single moment.But I need you to hear me clearly: this is not another COVID. The current public health risk from hantavirus remains low. My colleagues and I have said this unequivocally, and I will say it again to you now.The virus aboard the MV Hondius is the Andes strain of hantavirus. It is serious. Three people have lost their lives, and our hearts go out to their families. The risk to you, living your daily life in Tenerife, is low. This is the WHO’s assessment, and we do not make it lightly.Right now, there are no symptomatic passengers on board. A WHO expert is on that ship. Medical supplies are in place. Spain’s authorities have prepared a careful, step-by-step plan: passengers will be ferried ashore at the industrial port of Granadilla, far from residential areas, in sealed, guarded vehicles, through a completely cordoned-off corridor, and repatriated directly to their home countries. You will not encounter them. Your families will not encounter them.I also want to say something else, something that goes beyond the science.I personally thanked Prime Minister Sanchez for Spain’s decision to receive this ship. I called it an act of solidarity and moral duty. Because that is what it is. I want you to know that the WHO’s request to Spain was not made arbitrarily. It was made in full accordance with the International Health Regulations, the legally binding framework that defines the rights and obligations of countries and the WHO when responding to public health events of international concern. Under those rules, the nearest port with sufficient medical capacity must be identified to ensure the safety and dignity of those on board. Tenerife met that standard. Spain honoured it. Nearly 150 people from 23 countries have been at sea for weeks, some of them grieving, all of them frightened, all of them longing for home. Tenerife has been chosen because it has the medical capacity, the infrastructure, and the humanity to help them reach safety.And because I believe that so deeply, I will be there myself. I intend to travel to Tenerife to observe this operation firsthand, to stand alongside the health workers, port staff, and officials who are making it happen, and to personally pay my respects to an island that has responded to a difficult situation with grace, solidarity, and compassion. Your humanity deserves to be witnessed, not just acknowledged from a distance.As I have said many times: viruses do not care about politics, and they do not respect borders. The best immunity any of us has is solidarity.Tenerife is demonstrating that solidarity today. The ship’s captain, Jan Dobrogowski, crew and the company operating the vessel have shown exemplary collaboration at this challenging time.  On behalf of the World Health Organization, and on behalf of those passengers and their families around the world, I thank the people of Tenerife and everyone else involved.Please take care of yourselves and of each other. Trust in the preparations that have been made. And know that the WHO stands with you, and with every person on that ship, every step of the way.With respect, care, and gratitude,TedrosDr Tedros Adhanom GhebreyesusDirector-General, World Health Organization

Read full article →
News Cover
WHO мая 07, 2026

WHO’s response to hantavirus cases linked to a cruise ship

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, briefed media today on a cluster of hantavirus cases linked to a cruise ship, the MV Hondius.Eight cases have been reported so far, including three deaths. Five of the 8 cases have been confirmed as hantavirus.The hantavirus involved is the Andes virus, the only species known to be capable of limited transmission between humans, linked to close and prolonged contact.Describing the situation, Dr Tedros said, “While this is a serious incident, WHO assesses the public health risk as low.” He noted that given the incubation period, “it’s possible that more cases may be reported.”WHO is coordinating closely with multiple countries under the International Health Regulations or IHR, rules that define the rights and obligations of countries and WHO in responding to public health events. This event demonstrates why the IHR exist, demonstrating the importance of global cooperation and solidarity in responding to health threats that know no borders.“Our priorities are to ensure the affected patients receive care, that the remaining passengers on the ship are kept safe and treated with dignity, and to prevent any further spread of the virus,” Dr Tedros said.WHO has taken a number of actions since it was notified of the situation on Saturday, 2 May 2026. The latest of these include deploying an expert on board the ship, to support a comprehensive medical assessment of all passengers and crew, while gathering critical information to evaluate their risk of infection.WHO has arranged for the shipment of 2500 diagnostic kits from Argentina to laboratories in five countries to strengthen testing capacity. The Organization is also developing step-by-step operational guidance for the safe and respectful disembarkation and onward travel of passengers and crew when they arrive.Watch the full press conference 

Read full article →
News Cover
WHO мая 01, 2026

WHO Member States agree to extend negotiations on Pathogen Access and Benefit Sharing annex

Member States of the World Health Organization (WHO) have progressed work on the Pathogen Access and Benefit Sharing (PABS) annex, a key part of the WHO Pandemic Agreement, and today agreed additional time was needed to finalize the framework for ensuring a better, more equitable, response to future pandemics.Countries today ended the resumed session of the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement in Geneva, focused on the PABS system. The outcome of this work will be presented to the Seventy-ninth World Health Assembly (WHA) later this month. Given the need for further negotiations, the Assembly will be asked to consider continuing IGWG’s work as mandated in Resolution WHA78.1 and submit the outcome to the next Assembly in May 2027, or earlier by a special session of WHA in 2026.“Real progress was made on the PABS annex and I am confident through continued negotiations differences will be overcome,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Member States should continue approaching the outstanding issues with a sense of urgency because the next pandemic is a matter of when, not if. The PABS annex is the last piece of the puzzle not only for the Pandemic Agreement but all initiatives that WHO and Member States have implemented as a result of lessons learned from the COVID-19 pandemic.”The PABS system is intended to ensure, on equal footing, the rapid sharing of pathogens with pandemic potential and the fair and equitable sharing of benefits arising from their use, such as vaccines, diagnostics and therapeutics. Finalizing the PABS Annex is necessary so countries can proceed with signature and ratification of the Pandemic Agreement. “Finalizing a document of such technical and legal complexity requires precision and dedication, both of which the Member States have demonstrated in full,” said IGWG Bureau Co-Chair Ambassador Tovar da Silva Nunes of Brazil. “We are not there yet, but with an extension of our negotiations, we will get there.”IGWG Co-Chair Mr Matthew Harpur said: “WHO Member States have demonstrated strong and continuing commitment to negotiations on a Pathogen Access and Benefit Sharing system annex. The IGWG Bureau is confident we are moving in the right direction to finalize the PABS annex, and in doing so provide the WHO Pandemic Agreement with the framework needed to ensure countries are better, and more equitably, prepared and protected for the next pandemic.”The IGWG will hold its seventh meeting from 6 to 17 July 2026.In May 2025, the World Health Assembly adopted the WHO Pandemic Agreement to strengthen how countries prevent, prepare for, and respond to pandemics. It also established an open-ended Intergovernmental Working Group (IGWG) to carry out key tasks, including drafting and negotiating the PABS system.   

Read full article →
News Cover
WHO апр 27, 2026

Efforts to eliminate hepatitis delivers gains but more action needed to meet 2030 targets

Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health challenge, according to a new World Health Organization (WHO) report released today at the World Hepatitis Summit.Viral hepatitis B and C – the two infections responsible for 95% of hepatitis-related deaths worldwide – claimed 1.34 million lives in 2024, the latest data show. At the same time, transmission continues, with more than 4900 new infections every day, or 1.8 million each year.The 2026 Global hepatitis report documents significant gains made since 2015. The annual number of new hepatitis B infections has dropped by 32% and hepatitis C-related deaths have fallen by 12% globally. Hepatitis B prevalence among children under five has also decreased to 0.6%, with 85 countries achieving or surpassing the 2030 target of 0.1%.These achievements reflect the impact of sustained, coordinated global and national action following the adoption of WHO viral hepatitis elimination targets by Member States at the World Health Assembly in 2016. However, the report warns that current rates of progress are insufficient to meet all 2030 elimination targets, underscoring the urgent need to accelerate prevention, testing, and treatment efforts worldwide.“Around the world, countries are showing that eliminating hepatitis is not a pipedream, it's possible with sustained political commitment, backed by reliable domestic financing,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “At the same time, this report shows that progress is too slow and uneven. Many people remain undiagnosed and untreated due to stigma, weak health systems and inequitable access to care. While we have the tools to eliminate hepatitis as a public health threat, urgent scale-up of prevention, diagnosis and treatment is needed if the world is to meet the 2030 targets.”Global burden and gaps in responseUpdated WHO estimates indicate that 287 million people were living with chronic hepatitis B or C infection in 2024.That year, 0.9 million people were newly infected with hepatitis B. The WHO African Region accounted for 68% of new hepatitis B infections, yet only 17% of newborns in the region received the hepatitis B birth-dose vaccination.A further 0.9 million hepatitis C infections were recorded in 2024. People who inject drugs accounted for 44% of new infections, highlighting the urgent need for stronger harm reduction services and safe injection practices.Of the 240 million people with chronic hepatitis B in 2024, fewer than 5% were receiving treatment. Only 20% of people with hepatitis C have been treated since 2015, when a new 12-week treatment with a cure rate of about 95% became available.As a result of limited access to prevention and care, in 2024 an estimated 1.1 million people died from hepatitis B and 240 000 from hepatitis C. Liver cirrhosis and hepatocellular carcinoma were the main causes of hepatitis related deaths. A large share of hepatitis B-related deaths occurred in the African and Western Pacific Regions.Ten countries – Bangladesh, China, Ethiopia, Ghana, India, Indonesia, Nigeria, the Philippines, South Africa and Viet Nam – accounted for 69% of hepatitis B related deaths worldwide in 2024. Hepatitis C-related deaths are more geographically dispersed. In 2024, ten countries accounted for 58% of the global total: China, India, Indonesia, Japan, Nigeria, Pakistan, the Russian Federation, South Africa, the United States of America and Viet Nam.Proven solutionsDespite these challenges, progress in countries such as Egypt, Georgia, Rwanda, and the United Kingdom demonstrates that eliminating hepatitis as a public health problem is achievable with sustained commitment and investment.Highly effective tools are already available:hepatitis B vaccine protects more than 95% of vaccinated people against both acute and chronic infections;long-term antiviral treatment for hepatitis B can help effectively manage chronic infection and prevent severe liver disease; and hepatitis C short-course curative therapy lasting 8-12 weeks can cure more than 95% of infections.“The data shows that progress is possible but also reveals where we are falling short. Every missed diagnosis and untreated infection due to chronic viral hepatitis represents a preventable death,” said Dr Tereza Kasaeva, Director, WHO Department for HIV, TB, Hepatitis and Sexually Transmitted Infections. “Countries must move faster to integrate hepatitis services for people living with hepatitis B and C into primary care, and to reach the communities most affected.”The report identifies priority actions to accelerate hepatis elimination as a public health threat. These include scaling up treatment for chronic hepatitis B infection, particularly in the WHO African and Western Pacific regions, and expanding access to hepatitis C treatment in the WHO Eastern Mediterranean Region.It also calls for stronger political commitment and financing, improved coverage of hepatitis B birth-dose vaccination and expanded antiviral prophylaxis to prevent mother-to-child transmission of HBV infection, particularly in the WHO African Region. In addition, the report emphasizes the need to improve injection safety in both health-care settings and community practices, including through strengthened harm reduction services for people who inject drugs. 

Read full article →
News Cover
WHO апр 27, 2026

Practicing today for tomorrow’s emergencies – WHO convenes countries and partners to simulate response to major disease outbreak

The World Health Organization (WHO) wrapped up Exercise Polaris II, a 2-day high-level simulation exercise, based around an outbreak of a fictional new bacterium spreading across the world. Bringing together 26 countries and territories, 600 health emergency experts and over 25 partners, the exercise, which took place on 22 and 23 April, allowed countries to test their preparedness for pandemics and other major health emergencies, including activating their emergency workforce structures, information flow and coordination with each other, partners and WHO.Building on the success of Polaris I held in April 2025, which centered on a fictional virus, each participating country activated its emergency coordination structure and worked under real-life conditions to share information, align policies and surge their workforce.“Exercise Polaris II showed what is possible when we act together. It demonstrated that global cooperation is not optional – it is essential,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This is the purpose of the Global Health Emergency Corps: coordination across the emergency workforce, building trust, strengthening connections, and working as one across borders.”The simulation put two key WHO frameworks into practice, the Global Health Emergency Corps (GHEC) framework and the National health emergency alert and response framework, and explored the use of AI-enabled tools to support workforce organization and planning.The GHEC framework, published in June 2025, provides guidance on how countries can strengthen their health workforce to respond to emergencies based on the principles of sovereignty, equity and solidarity. It improves collaboration between countries by supporting information exchange and strengthening the deployment of regional and global emergency personnel when needed.The National health emergency alert and response framework, published in October 2025 outlines the key functions, coordination systems and actions needed for an effective response at local, sub-national and national levels.“By simulating the spread of a dangerous pathogen under real-life conditions, Exercise Polaris II helped us turn existing plans into action. It is not enough to have plans on paper – what matters is how they perform in practice,” said Edenilo Baltazar Barreira Filho, Director of the Public Health Emergencies Department, Ministry of Health, Brazil. The exercise also provided an opportunity to practice a coordinated provision of technical expertise and surge support to countries from over 25 national, regional and global health agencies and organizations, including Africa Centres for Disease Control and Prevention, the International Federation of Red Cross and Red Crescent Societies, Médecins Sans Frontières, Robert Koch Institute, UK-Med, UNICEF, and emergency networks such as the Global Outbreak Alert and Response Network, the Emergency Medical Teams initiative, Standby Partners, and the International Association of National Public Health Institutes.“Exercise Polaris II showed what it looks like when countries are prepared and ready to act together,” said Dr Chikwe Ihekweazu, Executive Director of WHO’s Health Emergencies Programme. “This reflects the spirit of the Global Health Emergency Corps: a well-organized, trained, coordinated and connected emergency workforce ready to respond wherever and whenever it is needed.”The second edition of the exercise saw a larger number of countries participate and collaborate through new networks such as the recently launched Health Emergency Leaders Network for Africa and the Eastern Mediterranean.Exercise Polaris II is part of HorizonX, WHO’s forward-looking, multi-year simulation exercise programme. It provides a vital platform to operationalize and practice emergency frameworks under real-life conditions, ensuring that collective readiness is not a periodic effort, but a continuous investment in global health security. Note to editorsParticipating countries and territories covering all WHO regions included Bangladesh, Brazil, Brunei, Colombia, Egypt, El Salvador, France, Georgia, Ghana, India, Indonesia, Jordan, Kenya, Kosovo*, Libya, Malaysia, Nepal, Oman, Paraguay, Philippines, Qatar, Republic of Congo, Rwanda, Suriname, Thailand, and Yemen.*All references to Kosovo on this page should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).About WHODedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the United Nations’ agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable.  “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO апр 24, 2026

WHO prequalifies first-ever malaria treatment for newborns and infants, adds new diagnostic tests

Ahead of World Malaria Day on 25 April, the World Health Organization (WHO) has announced a significant step forward in the fight against malaria with the prequalification of the first treatment developed specifically for newborns and young infants weighing between two and five kilograms. The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy, and will help to expand access to quality-assured treatment for one of the most underserved patient groups.The newly prequalified treatment, artemether-lumefantrine, is the first antimalarial formulation designed specifically for the youngest malaria patients. Until now, infants with malaria have been treated with formulations intended for older children, which increase the risk of dosing errors, side effects and toxicity. WHO prequalification will enable public sector procurement, contributing to closing a long-standing treatment gap for some 30 million babies born each year in malaria-endemic areas of Africa."For centuries, malaria has stolen children from their parents, and health, wealth and hope from communities," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "But today, the story is changing. New vaccines, diagnostic tests, next-generation mosquito nets and effective medicines, including those adapted for the youngest, are helping to turn the tide. Ending malaria in our lifetime is no longer a dream – it is a real possibility, but only with sustained political and financial commitment. Now we can. Now we must."New prequalified testsOn 14 April 2026, WHO also prequalified three new rapid diagnostic tests (RDTs) designed to address emerging diagnostic challenges for malaria. The most common malaria RDTs for P.falciparum parasite work by detecting the protein, known as HRP2. But based on reported studies and surveys in 46 countries, some strains of the malaria parasite have lost the gene that makes this protein – so they become "invisible" to HRP2-based RDTs, leading to false-negative results. In countries in the Horn of Africa, up to 80% of cases were missed, leading to delayed treatment, severe illness, and even death.The new tests address this issue by targeting a different parasite protein (pf-LDH) that the malaria parasite cannot easily shed. They provide a reliable, quality-assured alternative where HRP2-based tests are failing. WHO now recommends that countries switch to these alternative RDTs when more than 5% of cases are missed due to pf-hrp2 deletions. This ensures accurate diagnosis, appropriate treatment, and protects hard-won malaria control gains – especially for the most vulnerable communities.The announcements come as WHO and partners launch the 2026 World Malaria Day campaign, "Driven to End Malaria: Now We Can. Now We Must." The theme is a rallying cry to seize the moment – to protect lives now and fund a malaria-free future.According to the World malaria report 2025, there were an estimated 282 million cases and 610 000 deaths in 2024 – an increase from 2023. While 47 countries have been certified malaria-free and 37 countries reported fewer than 1000 cases in 2024, progress at the global level is stalling. Gains are at risk due to multiple challenges, including drug resistance, insecticide resistance, diagnostic failure, and severe reductions in international development assistance.Despite these challenges, substantial progress has been made, with an estimated 2.3 billion malaria infections prevented and 14 million lives saved worldwide since 2000.Twenty-five countries are now rolling out malaria vaccines, protecting millions of children, and next-generation mosquito nets make up 84% of all new nets distributed. These advances demonstrate what is possible when all partners work together to innovate and deliver on the promises towards ending malaria for all. About WHODedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable.“Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide. 

Read full article →
News Cover
WHO апр 23, 2026

Largest catch-up initiative delivers over 100 million childhood vaccinations

The Big Catch-Up, launched during World Immunization Week 2023, has delivered over 100 million vaccine doses to an estimated 18.3 million children across 36 countriesAround 12.3 million were “zero-dose children” who had not previously received any vaccines and 15 million who had never received a measles vaccine. The initiative concluded in March 2026 and is on track to meet its target of catching up 21 million children – but agencies warn that many infants still miss out on lifesaving vaccines through routine immunization every year.The Big Catch-Up (BCU), a historic multi-year, multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic, has reached an estimated 18.3 million children aged 1 to 5 across 36 countries with more than 100 million doses of life-saving vaccines, helping to narrow critical immunity gaps, announced Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF at the start of World Immunization Week.Of the 18.3 million children reached between 2023 and 2025, an estimated 12.3 million were “zero-dose children” who had not yet received a vaccine and 15 million had never received a measles vaccine. BCU also provided 23 million doses of inactivated polio vaccine (IPV) to un- and under-vaccinated children, an essential intervention to reach polio eradication. Programme implementation concluded on 31 March 2026. Although final data is still being compiled, the global initiative is forecasted to be on track to meet its target of reaching at least 21 million un- and under-immunized children.However, agencies warn that while catch-up vaccination is an important strategy for closing immunisation gaps, expanding the reach of routine immunization programmes remains the most effective and sustainable way to protect children and prevent outbreaks of vaccine-preventable diseases.Addressing the vaccine equity gapBeyond pandemic recovery, the BCU initiative focused on closing the vaccine equity gap. Millions of children every year miss the essential vaccinations they should receive before the age of one. Most of them live in fragile, conflict-affected, or underserved communities and are never caught up as they grow older.The 36 participating BCU countries across Africa and Asia currently account for 60% of all zero-dose worldwide. Pandemic-related immunisation programme disruptions exacerbated this issue, and, in these countries, added millions more zero-dose children to those who already chronically miss out. To address this issue, the Big Catch-Up looked beyond infant immunization, for the first-time ever systematically leveraging routine immunisation systems to make deep inroads into the accumulated global cohort of older children between the ages of 1 to 5 – “older” because they should have received critical routine vaccines before the age of 1 – who remain vulnerable due to missed vaccinations.BCU catalysed long-lasting systems to identify, screen, vaccinate and monitor coverage rates in these older children – including updates to policies on age eligibility. Countries also oriented and trained health workers to identify, screen and vaccinate missed children as part of routine care and engaged with communities and civil society to support catch-up efforts. By expanding the reach of immunization to millions of previously missed children and their communities, and investing in systemic improvements, the BCU drive has made it easier for the countries to ensure these populations and others like them continue to receive essential health and immunization services in the future.Among the participating countries, 12 countries (Burkina Faso, Democratic People’s Republic of Korea, Ethiopia, Kenya, Madagascar, Mauritania, Niger, Pakistan, Somalia, Togo, United Republic of Tanzania, and Zambia) reported reaching more than 60% of all zero-dose children under the age of 5 who had previously missed DTP1. In Ethiopia, more than 2.5 million previously zero-dose children received DTP1. The country also delivered nearly 5 million doses of IPV and more than 4 million doses of measles vaccine, among other key vaccines, to un- and under-vaccinated children. Countries outside this group also reached large numbers of children. In Nigeria, for example, 2 million previously zero-dose children were reached with DTP1, and 3.4 million doses of IPV were administered alongside millions of doses of other vaccines.While these 36 countries received Gavi funding and technical assistance from WHO and UNICEF through BCU, many other countries also implemented activities during this period to accelerate efforts to catch-up missed children and recover immunisation services following pandemic-related backsliding.“As the largest ever international effort to reach missed children with life-saving vaccines, the Big Catch-Up shows what is possible when governments, partners and communities work together to protect the most vulnerable in society,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “Thanks to this accomplishment, not only are millions of children now protected from preventable diseases but so are their communities, for generations to come.” "By protecting children who missed out on vaccinations because of disruptions to health services caused by COVID-19, the Big Catch-Up has helped to undo one of the pandemic's major negative consequences," said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. “The success of the Big Catch-Up is a testament to health workers and national immunization programmes, which are now better equipped to find and vaccinate children missed by routine services."   "Vaccinations save lives,” said UNICEF Executive Director Catherine Russell.  “This initiative shows what's possible when countries have the resources, tools, and political will to reach children with lifesaving vaccines. We've caught up with some of the children who missed routine vaccinations during the pandemic – but many more remain out of reach. The gains made through the Big Catch-Up must be sustained through investment in strong, reliable immunisation systems, especially at a time where measles is resurging."Looking at the challenges aheadThrough the Big Catch-Up, for the first time ever, countries and global partners successfully reached 12.3 million “older” zero dose children between the ages of 1 to 5. However, in 2024, an estimated 14.3 million infants under the age of one globally failed to receive a single vaccine through routine immunization programmes. Despite BCU demonstrating progress is possible with leadership and targeted investment and support, lowering this annual number of infants who miss out will require building systems that consistently reach the hardest to reach communities – against a backdrop of rising birth cohorts, conflict and displacement, funding cuts, and strained health systems.The consequences of chronic gaps in routine immunisation are plain to see. Measles outbreaks, for example, are rising in every region with around 11 million cases in 2024, and the number of countries facing large outbreaks has almost tripled since 2021. This surge is driven by persistent gaps in measles vaccination through routine immunization programmes, compounded by declining vaccine confidence in some previously high-coverage communities.Large-scale catch-up efforts are resource intensive and should serve only as a gap-filling measure that is complementary to routine immunization. Timely vaccination according to national immunisation schedules provides optimal protection and continues to be the most sustainable way to safeguard children and communities.For every generation, vaccines workWHO, UNICEF, and Gavi, along with countries and communities, are marking World Immunization Week (24–30 April 2026) with a joint campaign, "For every generation, vaccines work," calling on countries to sustain and expand vaccination coverage at every age. At the midpoint of the Immunisation Agenda 2030 (IA2030), and central to Gavi's 2026–2030 strategy (Gavi 6.0), the priority remains the same: reaching zero-dose children and advancing equity in the hardest-to-reach communities, particularly in countries grappling with conflict, instability, or fragile health systems. Maintaining that momentum will require expanding long-term domestic investments in immunization programmes and reliable commitments from partners and donors. Notes to editorsUseful linksPhotos and broll - UNICEFWHO catch up immunisationThe Big Catch-Up: An Essential Immunisation Recovery Plan for 2023 and BeyondAbout Gavi, the Vaccine AllianceGavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world’s deadliest diseases. The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Gates Foundation and other private sector partners. View the full list of donor governments and other leading organisations that fund Gavi’s work here.Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology – from drones to biometrics – to save lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Bluesky, Facebook, Instagram, LinkedIn, TikTok, X and YouTube.About UNICEFUNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential. For more information about UNICEF and its work, please visit: www.unicef.org Follow UNICEF on X (Twitter), Facebook, Instagram, and YouTubeAbout WHODedicated to the health and well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere, an equal chance at a safe and healthy life. We are the UN agency for health. We connect nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int     

Read full article →
News Cover
WHO апр 23, 2026

WHO reports measurable health impact in 2025 amid transition to new strategy

The World Health Organization (WHO) today released its Results Report, highlighting measurable improvements in people’s health worldwide in 2025, despite funding cuts affecting both the organization and the broader global health sector.Published at a pivotal moment for global health, the Results Report demonstrates that WHO’s impact was strongest in areas where its technical leadership and comparative advantage were fully leveraged.The report finds significant progress across all three “Triple Billion” targets under WHO’s Thirteenth General Programme of Work (GPW13) for 2019–2025.an estimated 567 million additional people were covered by essential health services without experiencing catastrophic health spending in 2025, compared with the baseline in 2018 – an increase of 136 million since 2024;an estimated 698 million additional people were better protected from health emergencies in 2025, compared with the baseline in 2018 – an increase of 61 million since 2024; andan estimated 1.75 billion additional people living healthier lives in 2025, compared with the baseline in 2018 – an increase of 300 million since 2024.Despite this progress, the report cautions that important ambitions remain unmet, leaving with the world off track to meet the health-related Sustainable Development Goals by 2030.Nevertheless, this final snapshot under GPW 13 provides clear evidence of the value of a strong and sustainably financed WHO, reflecting enduring collaboration between WHO and its Member States at global, regional and country levels.“The Results Report 2025 shows that with support from WHO and partners, countries have delivered tangible benefits for millions of people,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “At the same time, these gains cannot be taken for granted. Protecting and expanding them will require sustained support and investment, so that together we can continue advancing the vision set out in WHO’s Constitution: the highest attainable standard of health as a right for all.”The WHO Results Report is released annually ahead of the World Health Assembly to assess progress and review achievements and challenges in implementing WHO’s programme budget.Compared with previous editions, the 2025 report features stronger evidence-based reporting and clearer prioritization across country, regional and global levels, providing a more data-driven picture of where progress has been made and where further effort is needed. The full report will be presented by the Director-General at the Seventy-ninth World Health Assembly (18–23 May 2026).Significant impact and areas of improvementThis latest Results Report shows meaningful – but incomplete – progress across 46 outcome indicators and 121 output indicators that are specifically focused on the performance of the WHO Secretariat. These indicators are aligned with the 2030 Agenda for Sustainable Development reflecting joint accountability between WHO and its Member States.Overall, approximately half of the output indicators were not achieved, particularly in emergency-prone and resource-constrained settings. For all three targets, financial pressures and WHO’s realignment process had several immediate consequences, such as reduced human resource capacity for delivery, limited technical support, and slowing programme implementation.Progress towards universal health coverage was driven by expanded coverage of services for communicable diseases, including HIV and tuberculosis, prevention of bacterial diseases through improved sanitation and an expanding health workforce. However, gaps persist in areas such as diabetes management, measles surveillance and financial protection.Progress under protection from health emergencies reflects advances in pandemic preparedness, early warning systems, prevention and response capacity. These gains were supported in part by the adopted Pandemic Agreement and the revised International Health Regulations. Areas requiring complex implementation – such as disease detection, emergency response, and polio eradication and transition – remain more challenging, reflecting constraints in country capacity, financing and operations.Progress towards better health and well-being was driven by improvements in access to clean household energy, water, sanitation and hygiene, and reductions in air pollution, tobacco use and alcohol consumption. WHO’s global guidance, technical tools, standards and networks played a significant role in supporting these achievements.Examples of achievements in 2025The Results Report highlights several areas where WHO’s technical leadership and convening role delivered clear impact:antimicrobial resistance: expanded surveillance and evidence generation through the Global Antimicrobial Resistance and Use Surveillance System (GLASS), for policy-decision making;mental health: strengthened emergency mental health and psychosocial support systems, increasing country coverage from 28% to 48%;HPV vaccination: expanded vaccine coverage with simplified single-dose schedules, raising global coverage from 17% in 2019 to 31% in 2024;pandemic preparedness: adoption of the Pandemic Agreement and amendments to the International Health Regulations (IHR), to ensure that the world is better prepared for future pandemics;humanitarian response: responded to 66 emergencies across 88 countries in 2025; delivering for instance 33 million medical consultations through health partners in Gaza.environmental health: updated global air pollution roadmap to cut deaths attributed to poor air quality by 50% by 2040; andOne Health: strengthened high-level engagement and multisectoral dialogue and collaboration through the Quadripartite partnership, to better protect people, animals and the planet from future health crises.Looking aheadThe report notes that a large share of WHO’s funding remains highly earmarked for specific thematic areas, which continues to limit strategic allocation in line with organizational priorities.As the global financial landscape becomes more constrained, sustained and flexible financing will be essential to safeguard health gains, reduce persistent inequities, and enable WHO to deliver on its mandate – particularly in countries and communities most in need – for a healthier, safer, and fairer world for all.Editor’s noteEstablished under GPW 13, WHO’s Triple Billion targets aimed to ensure that, by the end of 2025 compared with 2018 levels, one billion more people benefit from universal health coverage; one billion more people are better protected from health emergencies; and one billion more people enjoy better health and well-being. 

Read full article →
News Cover
WHO апр 22, 2026

WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV

In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.“I congratulate The Bahamas on this outstanding achievement, which solidifies years of political commitment, and the dedication of health workers,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “By ensuring that children are born free of HIV, we are securing a healthier, brighter future for the next generation.”“This achievement reflects sustained political commitment and strong national leadership, alongside the dedication and compassion of the health workforce,” said Dr Jarbas Barbosa, Director of the Pan American Health Organization (PAHO) and WHO Regional Director for the Americas. “As we look ahead, this milestone is not only a moment of national pride but also an opportunity to build on this success, advancing efforts to end HIV and other communicable diseases as public health threats across the Caribbean and the Americas.”Foundations of successThe Bahamas achieved this milestone by pioneering a comprehensive and inclusive health-care model. Key to this success has been the provision of universal antenatal care to all pregnant women, regardless of nationality or legal status, across both public and private facilities. This approach is supported by a strong, integrated laboratory network and a rigorous testing protocol that screens women at their first antenatal appointment and again in the third trimester.Elimination of mother-to-child transmission (EMTCT) interventions in The Bahamas are fully integrated into antenatal care standards and norms and implemented under the Maternal and Child Health (MCH) programme. MCH coordinates with the National Infectious Disease Programme, which oversees the prevention and treatment of HIV and other sexually transmitted infections (STI). This includes the introduction of pre-exposure prophylaxis (PrEP) for HIV prevention, also offered to pregnant women. To ensure continuity of care, the health system maintains adequate monitoring for HIV-positive mothers and exposed infants, provides multi-month dispensing of antiretroviral medicines, and offers STI treatment and family planning services free of charge.“For years, The Bahamas have been working very hard to address the situation of HIV/AIDS,” said Dr Michael Darville, Minister of Health and Wellness of The Bahamas. “A lot of people have been involved in us achieving this great milestone – our nurses in our public health system, our nurses and doctors in our tertiary health-care system and, by extension, all of the clinics spread throughout our archipelago.”From Cuba, the first country in the world to be certified, and Brazil – certified last year, The Bahamas now joins a prestigious group of 12 countries and territories in the Region of the Americas at the forefront of the EMTCT movement. The Bahamas will continue efforts to sustain these standards through integrated primary care and continuous surveillance.The road to eliminationTo receive WHO certification, countries must prove they have sustained the following:reducing the mother-to-child transmission rate of HIV to less than 2%;achieving fewer than 5 new pediatric HIV infections per 1000 live births; andmaintaining 95% or higher coverage for antenatal care, HIV testing, and treatment for pregnant women.“Latin America and the Caribbean has long been a beacon of progress in this global effort. From Cuba – the first country in the world to be certified – to Brazil’s certification last year, and now to The Bahamas, the region continues to lead with ambition and determination. Today, more than half of all countries and territories that have achieved elimination are from this region. This is a legacy of leadership that inspires the world,” said Anurita Bains, Global Associate Director for HIV/AIDS at UNICEF.“The Bahamas are showing that eliminating mother-to-child transmission HIV and other sexually transmitted infections is possible,” said Winnie Byanyima, UNAIDS Executive Director. “This achievement reflects political will for steady investment in primary health care and the work of health teams and people living with and most affected by HIV. When women can test early in pregnancy, start treatment quickly, and stay in care, every child has a better chance of being born free of HIV and other STIs.”The Bahamas’ success is part of the broader EMTCT Plus Initiative, which aims to eliminate mother-to-child transmission of HIV, syphilis, hepatitis B, and congenital Chagas disease. Implemented in collaboration with UNICEF and UNAIDS, the initiative is embedded within PAHO’s Elimination Initiative, a regional effort to eliminate more than 30 communicable diseases and related conditions in the Americas by 2030.

Read full article →
News Cover
WHO мар 17, 2026

Прогресс в снижении детской смертности замедляется, поскольку 4,9 миллиона детей умирают в возрасте до пяти лет

Согласно новым оценкам, опубликованным сегодня, в 2024 году, по оценкам, 4,9 миллиона детей умерли, не дожив до пяти лет, в том числе 2,3 миллиона новорожденных. Большинство этих смертей можно предотвратить с помощью проверенных, недорогих мер и доступа к качественному медицинскому обслуживанию. Уровни и тенденции детской смертности – смертность среди детей в возрасте до пяти лет во всем мире снизилась более чем вдвое с 2000 года. Однако с 2015 года темпы снижения детской смертности замедлились более чем на 60 процентов. впервые – полностью интегрирует оценки причин смерти.*Впервые в отчете оцениваются случаи смерти, непосредственно вызванные тяжелой острой недостаточностью питания (SAM), при этом обнаруживается, что более 100 000 детей в возрасте от 1 до 59 месяцев – или 5 процентов – умерли от него в 2024 году. Число жертв намного выше, если принять во внимание косвенные последствия, поскольку недоедание ослабляет детский иммунитет и увеличивает риск смерти от распространенных детских болезней. Данные о смертности также часто не отражают SAM как основную причину смерти, что позволяет предположить, что это бремя, вероятно, существенно недооценено. В число стран с наибольшим количеством прямых смертей входят Пакистан, Сомали и Судан. Смертность новорожденных составляет почти половину всех смертей детей в возрасте до пяти лет, что отражает более медленный прогресс в предотвращении смертности во время рождения. Ведущими причинами среди новорожденных были осложнения в результате преждевременных родов (36 процентов) и осложнения во время родов (21 процент). Инфекции, в том числе неонатальный сепсис и врожденные аномалии, также были важными причинами. После первого месяца основными смертельными случаями были инфекционные заболевания, такие как малярия, диарея и пневмония. Малярия оставалась крупнейшим убийцей в этой возрастной группе (17 процентов) – при этом большинство смертей происходит в эндемичных районах Африки к югу от Сахары. После резкого снижения смертности от малярии в период с 2000 по 2015 год прогресс в снижении смертности от малярии в последние годы замедлился. Смертность по-прежнему сосредоточена в нескольких эндемичных странах – такие как Чад, Демократическая Республика Конго, Нигер и Нигерия – где конфликты, климатические потрясения, инвазивные комары, устойчивость к лекарствам и другие биологические угрозы продолжают влиять на доступ к профилактике и лечению. Детская смертность по-прежнему сконцентрирована в небольшом числе регионов. В 2024 году на страны Африки к югу от Сахары приходилось 58 процентов всех случаев смерти детей в возрасте до пяти лет. В регионе основные инфекционные заболевания стали причиной 54 процентов всех случаев смерти детей в возрасте до пяти лет. В Европе и Северной Америке эта доля снижается до 9 процентов, а в Австралии и Новой Зеландии — до 6 процентов. Эти резкие различия отражают неравный доступ к проверенным, спасающим жизни вмешательствам. включая преждевременные роды, родовую асфиксию/травму, врожденные аномалии и неонатальные инфекции. Эти в значительной степени предотвратимые состояния подчеркивают острую необходимость инвестиций в качественную дородовую помощь, квалифицированный медицинский персонал при родах, уход за маленькими и больными новорожденными, а также в основные услуги для новорожденных. Дети, рожденные в этих местах, почти в три раза чаще умирают до достижения пятилетнего возраста, чем дети в других местах. В докладе также говорится, что, по оценкам, в 2024 году умерло 2,1 миллиона детей, подростков и молодых людей в возрасте от 5 до 24 лет. Инфекционные заболевания и травмы остаются основными причинами среди детей младшего возраста, в то время как риски смещаются в подростковом возрасте: членовредительство является основной причиной смерти среди девочек в возрасте 15–19 лет, а дорожно-транспортные происшествия среди мальчиков. В глобальной системе финансирования развития важнейшие программы охраны здоровья матерей, новорожденных и детей оказываются под растущим давлением. Обследования, информационные системы здравоохранения и основные функции, лежащие в основе эффективного ухода, нуждаются в устойчивом финансировании не только для защиты достигнутого прогресса, но и для его ускорения. Фактические данные показывают, что инвестиции в здоровье детей остаются одними из наиболее экономически эффективных мер развития. Проверенные и недорогие меры – такие как вакцины, лечение тяжелой острой недостаточности питания и квалифицированная помощь при рождении – доставить некоторые из

Read full article →
News Cover
WHO мар 11, 2026

Конфликт усугубляет кризис здравоохранения на Ближнем Востоке, заявили в ВОЗ

Прошло более десяти дней с момента последней эскалации конфликта на Ближнем Востоке, и системы здравоохранения по всему региону испытывают напряжение из-за роста травматизма и перемещения населения, продолжающихся нападений на системы здравоохранения и увеличения рисков для общественного здравоохранения. Национальные органы здравоохранения в Иране сообщают о более чем 1300 смертях и 9000 ранениях, а в Ливане сообщают о как минимум 570 смертях и более 1400 ранениях. В Израиле власти сообщают о 15 погибших и 2142 раненых. В то же время конфликт влияет на те самые службы, призванные спасать жизни. В Иране ВОЗ подтвердила 18 нападений на медицинские учреждения с 28 февраля, в результате которых 8 человек погибли среди медицинских работников. За тот же период в Ливане в результате 25 нападений на медицинские учреждения 16 человек погибли и 29 получили ранения. Эти нападения не только уносят жизни людей, но и лишают общины медицинской помощи, когда они в ней больше всего нуждаются. Медицинские работники, пациенты и медицинские учреждения всегда должны быть защищены в соответствии с международным гуманитарным правом. Помимо непосредственных последствий, конфликт создает более широкие риски для общественного здравоохранения. По текущим оценкам, более 100 000 человек в Иране переехали в другие районы страны из-за отсутствия безопасности, а до 700 000 человек были перемещены внутри страны в Ливане, причем многие из них находятся в переполненных коллективных убежищах в условиях ухудшения состояния здоровья населения, с ограниченным доступом к безопасной воде, санитарии и гигиене. Эти условия повышают риск респираторных инфекций, диарейных заболеваний и других инфекционных заболеваний, особенно для наиболее уязвимых групп населения, таких как женщины и дети. Экологические опасности также вызывают серьезную озабоченность. В Иране нефтяные пожары и дым от поврежденной инфраструктуры подвергли близлежащие общины воздействию токсичных загрязнителей, которые потенциально могут вызвать проблемы с дыханием, раздражение глаз и кожи, а также загрязнение воды и источников пищи. Доступ к медицинским услугам становится все более ограниченным в нескольких странах. В Ливане 49 центров первичной медико-санитарной помощи и пять больниц закрылись после приказа об эвакуации, изданного израильскими военными, что снизило доступность основных услуг по мере роста медицинских потребностей. доступ через несколько провинций на Западном Берегу. В секторе Газа медицинская эвакуация остается приостановленной с 28 февраля, в то время как больницы продолжают работать в напряженном режиме из-за продолжающейся нехватки лекарств, предметов медицинского назначения и топлива, которое нормируется с учетом приоритетности основных медицинских услуг, таких как неотложная и травматологическая помощь, услуги матери и новорожденного, а также лечение инфекционных заболеваний. Временные ограничения в воздушном пространстве нарушили движение предметов медицинского назначения из глобального логистического центра ВОЗ в Дубае. Это затронуло более 50 запросов на поставки экстренной помощи, предназначенных для помощи более чем 1,5 миллионам человек в 25 странах, что привело к значительным задержкам. Текущие приоритетные поставки включают поставки, запланированные в Эль-Ариш (Египет) для поддержки ответных мер в секторе Газа, а также в Ливан и Афганистан. Ожидается, что первая партия, содержащая средства борьбы с холерой для Мозамбика, отправится из центра на предстоящей неделе. Эскалация ситуации происходит в то время, когда гуманитарные потребности в регионе Восточного Средиземноморья уже были одними из самых высоких в мире. Во всем регионе 115 миллионов человек нуждаются в гуманитарной помощи – почти половина всех нуждающихся людей во всем мире – в то время как призывы к оказанию чрезвычайной гуманитарной медицинской помощи остаются на 70% недофинансированными. Без защиты здравоохранения, устойчивого гуманитарного доступа и более сильной финансовой и оперативной поддержки гуманитарных мер в области здравоохранения нагрузка на уязвимые группы населения и и без того хрупкие системы здравоохранения будет продолжать расти.

Read full article →
News Cover
WHO фев 23, 2026

Нападения на здравоохранение в Украине увеличились на 20% в 2025 году

Поскольку Украина вступает в пятый год полномасштабной войны, ее народ в 2025 году пережил наибольшее количество нападений на свое здравоохранение – увеличится почти на 20% по сравнению с 2024 годом. С начала полномасштабной войны 24 февраля 2022 года ВОЗ задокументировала как минимум 2881 нападение на здравоохранение в Украине, от которых пострадали медицинские работники, учреждения, машины скорой помощи и медицинские склады. Службы здравоохранения находятся под сильным давлением на двух фронтах: прямые нападения на здравоохранение и каскадные последствия ударов по гражданской инфраструктуре, включая тепловые электростанции, которые лежат в основе энергосистемы страны. Это привело к глубоким пробелам в состоянии здоровья людей. Согласно оценке ВОЗ, проведенной в декабре 2025 года, 59% людей в прифронтовых районах сообщили о своем здоровье как плохое или очень плохое по сравнению с 47% в неприфронтовых районах. «После четырех лет войны потребности в медицинской помощи растут, но многие люди не могут получить необходимую им помощь, отчасти потому, что больницы и клиники регулярно подвергаются нападениям», — заявил д-р Тедрос Адханом Гебрейесус, генеральный директор ВОЗ. «ВОЗ работает вместе с преданными своему делу работниками здравоохранения Украины, чтобы обеспечить больницы средствами для поддержания тепла и лекарствами, на которые люди полагаются больше всего. В конечном счете, лучшее лекарство - это мир». В 2025 году поддержка ВОЗ достигла 1,9 миллиона человек по всей Украине благодаря предоставлению услуг, медикаментам, направлениям и наращиванию потенциала, с особым упором на прифронтовые и труднодоступные места». Кризис в Украине», — заявил д-р Ханс Анри П. Клюге, директор Европейского регионального бюро ВОЗ. «Потребности в области психического здоровья ошеломляют: 72% опрошенных людей испытывали тревогу или депрессию в прошлом году, однако только каждый пятый обратился за помощью. Сердечно-сосудистые заболевания растут: каждый четвертый украинец страдает от опасно высокого кровяного давления. И 8 из 10 человек сообщают, что не могут получить доступ к необходимым им лекарствам. Это не абстрактно – это пациент с сердечным заболеванием, который не может найти лекарство от артериального давления, инвалид с ампутированной конечностью, месяцами ожидающий протеза, подросток, слишком боящийся выйти из дома. Система здравоохранения Украины нуждается в нашей постоянной поддержке». Нападки на здравоохранение В год, отмеченный надеждами на мирные переговоры, реальность на местах говорила об ином. Нападения на здравоохранение усилились, достигнув пика в третьем квартале 2025 года, когда 184 нападения унесли жизни 12 человек и ранили 110 медицинских работников и пациентов. В то же время количество нападений на медицинские склады в 2025 году утроилось по сравнению с предыдущим годом, что нарушило логистику и цепочки поставок, которые имеют решающее значение для оказания медицинской помощи по всей стране. За последние четыре года 233 медицинских работника и пациента были убиты и 930 получили ранения в результате нападений на медицинские учреждения. Подобные нападения представляют собой нарушение международного гуманитарного права. Последствия разрушений для основных служб здравоохранения Эта зима была самой суровой с начала войны: многочисленные удары по энергетической инфраструктуре оставили миллионы людей без отопления, электричества и воды. Многие теплоэлектростанции Украины были повреждены или разрушены. Только в Киеве в результате теракта в январе 2026 года около 6000 зданий остались без тепла в условиях минусовой температуры, в результате чего, по оценкам, 600 000 жителей покинули столицу. «То, что мы наблюдаем в Украине, — это разрушительный цикл. Повреждена теплостанция, и тысячи домов теряют тепло в течение нескольких часов. При температуре – 20°C вода в трубах замерзает, разрывает их, заливает здания льдом. Затем проводится ремонт. За каждым из этих сбоев системы стоят семьи, пожилые жители и работники здравоохранения, которые должны продолжать спасать жизни, в то время как их собственные дома остаются без тепла, воды и электричества. Выгорание после четырех лет войны огромно – и спрос на медицинскую помощь никогда не был таким высоким», – сказал д-р Ярно Хабихт, представитель ВОЗ в Украине. Последствия не заканчиваются у дверей больницы. Молодые матери, выписанные после родов, пациенты, выздоравливающие после травм или сердечных приступов, а также те, кто ожидает или восстанавливается после критических онкологических операций, возвращаются домой в квартиры без отопления, электричества и водопровода. Помощь, которая начинается в функционирующей больнице, подрывается, когда пациенты выздоравливают в холодных, темных домах, превращая прогресс медицины в ежедневную борьбу за выживание.

Read full article →
News Cover
WHO фев 05, 2026

Более четырех миллионов девочек все еще подвергаются риску калечащих операций на женских половых органах: лидеры ООН призывают к устойчивой приверженности и инвестициям, чтобы положить конец КОЖПО

Совместное заявление исполнительного директора ЮНФПА, исполнительного директора ЮНИСЕФ, Верховного комиссара ООН по правам человека, исполнительного директора Структуры «ООН-женщины», генерального директора ВОЗ и генерального директора ЮНЕСКО по случаю Международного дня нулевой терпимости к калечащим операциям на женских половых органах. Только в 2026 году около 4,5 миллиона девочек – многие младше пяти лет – подвергаются риску подвергнуться калечащим операциям на женских половых органах (КОЖПО). В настоящее время более 230 миллионов девочек и женщин страдают от ее пожизненных последствий. Сегодня, в Международный день нулевой терпимости к калечащим операциям на женских половых органах, мы подтверждаем нашу приверженность положить конец калечащим операциям на женских половых органах для каждой девушки и каждой женщины, подвергающейся риску, и продолжать работать над тем, чтобы те, кто подвергся этой вредной практике, имели доступ к качественным и соответствующим услугам. Калечащие операции на женских половых органах являются нарушением прав человека и не могут быть оправданы ни на каких основаниях. Это компрометирует девочек». и физическое и психическое здоровье женщин и могут привести к серьезным осложнениям на всю жизнь, при этом затраты на лечение оцениваются примерно в 1,4 миллиарда долларов США в год. Мероприятия, направленные на прекращение калечащих операций на женских половых органах за последние три десятилетия, оказывают влияние, причем почти две трети населения в странах, где оно распространено, выражают поддержку его искоренению. После десятилетий медленных перемен прогресс в борьбе с калечащими операциями на женских половых органах ускоряется: половина всех успехов с 1990 года была достигнута за последнее десятилетие, сократив число девочек, подвергшихся КОЖПО, с одной из двух до одной из трех. Нам необходимо использовать этот импульс и ускорить прогресс для достижения цели устойчивого развития – положить конец калечащим операциям на женских половых органах к 2030 году. Мы знаем, что работает. Санитарное просвещение, привлечение религиозных и общественных лидеров, родителей и работников здравоохранения, а также использование традиционных и социальных сетей являются эффективными стратегиями прекращения этой практики. Мы должны инвестировать в движения, возглавляемые сообществом – – включая массовые и молодежные сети – и укреплять образование посредством как формальных, так и общественных подходов. Нам необходимо усилить профилактическую информацию, привлекая к этому надежных лидеров общественного мнения, в том числе работников здравоохранения. И мы должны поддержать выживших, обеспечив им доступ к комплексному, адаптированному к контексту медицинскому обслуживанию, психосоциальной поддержке и юридической помощи. Каждый доллар, вложенный в прекращение калечащих операций на женских половых органах, приносит десятикратную отдачу. Инвестиции в размере 2,8 миллиарда долларов США могут предотвратить 20 миллионов случаев заболевания и принести 28 миллиардов долларов США инвестиционной прибыли. По мере приближения к 2030 году достижения, достигнутые за десятилетия, находятся под угрозой, поскольку глобальные инвестиции и поддержка ослабевают. Сокращение финансирования и снижение международных инвестиций в программы здравоохранения, образования и защиты детей уже ограничивают усилия по предотвращению калечащих операций на женских половых органах и поддержке выживших. Кроме того, растущее систематическое сопротивление усилиям по прекращению калечащих операций на женских половых органах, усугубляемое опасными аргументами о том, что это приемлемо, если их проводят врачи или работники здравоохранения, добавляет еще больше препятствий на пути усилий по ликвидации. Без адекватного и предсказуемого финансирования программы работы с населением рискуют быть свернутыми, службы первой помощи ослаблены, а прогресс обращен вспять – подвергая риску еще миллионы девочек в критический момент на пути к достижению цели 2030 года. Сегодня мы подтверждаем нашу приверженность и усилия с местными и глобальными государственными и частными партнерами, включая пострадавших, чтобы положить конец калечащим операциям на женских половых органах раз и навсегда. 

Read full article →
News Cover
WHO янв 23, 2026

Countries progress negotiations in support of WHO Pandemic Agreement

The World Health Organization (WHO) Member States this week advanced their negotiations on the Pathogen Access and Benefit‑Sharing (PABS) system in a resumed session of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement. The PABS system is a core element of the agreement adopted by the World Health Assembly (WHA) in May 2025.During the session held on 20–22 January 2026, Member States continued text‑based negotiations on outstanding issues in the draft annex and exchanged views aimed at narrowing differences and identifying areas of convergence.“I am encouraged by the progress we have made in several areas, with signs of emerging consensus for some parts of the Pathogen Access and Benefit‑Sharing system,” said IGWG Bureau co‑chair Ambassador Tovar da Silva Nunes, of Brazil. “As we look ahead to the fifth session, the focus will be on the outstanding, complex issues. The resumed session has helped us gain a clearer picture of where we stand.” Established by the WHA, the IGWG is tasked, as a priority, with drafting and negotiating the PABS system, which is intended to enable safe, transparent and accountable sharing of pathogens with pandemic potential and their genetic sequence information, alongside the fair and equitable sharing of benefits arising from their use, including vaccines, therapeutics and diagnostics.The resumed session was held following a request by Member States to extend the fourth meeting of the IGWG, which convened in December 2025.“Member States have engaged in constructive discussions this week," said IGWG Bureau co-chair Mr Matthew Harpur, of the United Kingdom. "As we make progress towards the May deadline, I am encouraged by their willingness to work together and bridge differences to deliver an effective Pathogen Access and Benefit‑Sharing system."Further meetings of the IGWG are scheduled in the coming months as Member States continue their negotiations.“A strong Pathogen Access and Benefit‑Sharing system will be a cornerstone of a safer and more equitable world,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “I thank countries for their commitment to multilateral solutions.”The outcome of IGWG’s work will be submitted to the Seventy‑ninth World Health Assembly in May 2026 for its consideration. 

Read full article →
News Cover
WHO янв 21, 2026

WHO renews commitment to a leprosy-free world, spotlighting partnership and progress ahead of World Leprosy Day

Access to treatment for leprosy is essential to global efforts to eliminate leprosy, says the World Health Organization (WHO) ahead of World Leprosy Day, to be observed on 25 January.Leprosy is an infectious disease caused by a type of bacteria, Mycobacterium leprae, and is one of the oldest diseases known to humanity. The disease predominantly affects the skin and peripheral nerves. Left untreated, the disease may cause progressive and permanent disabilities and causes stigma and social isolation. However, the disease can be cured with multidrug therapy (MDT).Efforts to eliminate leprosy have been leading to reductions in the number of new cases in many areas; of the 188 countries, areas or territories that submitted data in 2024, 55 reported zero cases. But still 172 717 new cases were detected worldwide and reported to WHO in the same year.Many partners, including pharmaceutical companies such as Novartis, have been strong supporters of efforts to eliminate leprosy. WHO has collaborated with Novartis since 2000 to provide MDT and clofazimine, free of cost, to all leprosy patients worldwide. This partnership remains one of the most sustained pharmaceutical donation programmes in global health.Marking 25 years of partnership, WHO and Novartis have extended a Memorandum of Understanding (MoU) for an additional 5 years (2026−2030). The extension makes provision for continued supply of MDT and clofazimine, and also includes funding for procurement and distribution of single dose rifampicin (SDR) for post-exposure prophylaxis (PEP).“The unwavering commitment of partners like Novartis over the past quarter-century has been foundational to the progress made against leprosy,” said Dr Jeremy Farrar, WHO Assistant Director-General for Health Promotion, Disease Prevention and Care. “Their steadfast support in ensuring free access to treatment has helped transform millions of lives and moved us closer to a world free from this ancient disease. This enduring collaboration exemplifies the power of global solidarity in health – a reminder that, together, we can overcome even the oldest and most entrenched health challenges when science, equity, and partnership align.”Availability of free MDT has made it possible to cure the disease, prevent disabilities, mitigate stigma, and has enabled affected individuals to continue working and leading normal lives. Additionally, clofazimine has ensured the treatment of lepra reactions, which are characterized by sudden, severe inflammatory episodes, leading to disabilities, if left untreated.“Leprosy is one of the oldest infectious diseases known to humanity and combatting it has been part of our company’s history since discovering the first effective cure,” said Dr Lutz Hegemann, President of Global Health at Novartis. “Over the last 25 years, we have reached millions of patients together with WHO, and we are committed to going further to pursue our vision of a world free of leprosy.”While significant progress has been made, sustaining and building on this momentum requires political commitment, community engagement and continued collaboration and partnership.The theme for this year’s World Leprosy Day is “Leprosy is curable, the real challenge is stigma”.This year also marks the 25th anniversary of Mr Yohei Sasakawa’s work as the WHO Goodwill Ambassador for Leprosy Elimination. He said, “One of the most stubborn challenges that I encounter on my travels is the social stigma attached to leprosy, which can be more problematic than the disease itself, and which can persist beyond the end of treatment. This is particularly true for people who have been left with residual disabilities as a result of leprosy. They may face various forms of discrimination, including forced divorce, lost educational opportunities and unfair dismissal. Even after being cured, they endure the unending pain of social exclusion.”As leprosy is one of the target diseases under the broader umbrella of Neglected Tropical Diseases (NTDs), this work also supports the unified global effort towards a world free of NTDs. Learn more about the collective action and join our campaign on World NTD Day 2026 on 30 January. Notes for editorsThe NTD Roadmap 2021-2030 aims at elimination of leprosy (interruption of transmission). The Global Leprosy Strategy 2021–2030 underpinning the Roadmap, shifts the paradigm beyond the achievement of ‘elimination of leprosy as a public health problem’ toward interruption of transmission and elimination of leprosy disease. Contact screening along with scale-up of preventive chemotherapy and mitigation of stigma and discrimination constitute key pillars of this strategy. Beyond working to ensure that every person affected by leprosy is detected early and treated promptly, WHO leads efforts to combat the discrimination that persons affected by leprosy too often face.  

Read full article →
News Cover
WHO янв 12, 2026

Sudan: 1000 days of war deepen the world’s worst health and humanitarian crisis

Today, the conflict in Sudan reaches its 1000th day, with over 20 million people requiring health assistance and 21 million desperately needing food.Nearly three years of continuous violence, severe access constraints, and reduced funding have turned Sudan into the worst humanitarian crisis globally. An estimated 33.7 million people will need humanitarian aid this year.The health system has been severely damaged by ongoing fighting, increasingly deadly attacks on health care, mass displacement, lack of essential medical supplies, and shortages of health personnel and funding. Despite sustained efforts by WHO and partners to restore and revive health services across the country, more than one third of health facilities (37%) remain non-functional, depriving millions of people of essential and lifesaving health services.Since the start of the conflict in April 2023, WHO has verified 201 attacks on health care, resulting in 1858 deaths and 490 injuries. These attacks, which violate international humanitarian law, undermine access to lifesaving care and put health care workers, patients and caregivers at grave risk.“One thousand days of conflict in Sudan have driven the health system to the brink of collapse. Under the strain of disease, hunger and a lack of access to basic services, people face a devastating situation,” said WHO Representative in Sudan, Dr Shible Sahbani. “WHO is doing what we can, where we can, and we know we are saving lives and rebuilding the health system. Despite the challenges, we are also working on recovery of the health system.”The level of displacement is unprecedented. An estimated 13.6 million people are currently displaced, making Sudan the largest displacement crisis in the world. Fueled by poor living conditions, overcrowding in displacement sites, disrupted health and water, sanitation and hygiene services, and a breakdown of routine immunization, disease outbreaks are spreading, compounding the crisis. WHO is currently supporting the response to outbreaks of cholera, dengue, malaria, and measles, with cholera being reported from all 18 states, dengue from 14 states, and malaria from 16 states. Access to preventive and curative care, including for the management of chronic conditions and severe malnutrition, remains limited.WHO works with Sudan’s Federal and State Ministries of Health and partners to improve access to critical health services across Sudan and rehabilitate the health system. Since the start of the conflict in April 2023, WHO has delivered 3378 metric tons of medicines and medical supplies worth about US$ 40 million, including diagnostic supplies, treatments for malnutrition, and diseases such as cholera, malaria, dengue, and emergency surgery, to 48 health partners for lifesaving operations. About 24 million people have received cholera vaccinations, and WHO has supported the country to introduce and scale up malaria vaccines. Additionally, more than 3.3 million people have accessed health care at WHO-supported hospitals, primary health care facilities, and temporary mobile clinics. More than 112 400 children with severe acute malnutrition with medical complications have received treatment at functional stabilization centres, all of which receive lifesaving WHO nutrition supplies. State and National public health laboratories have been equipped and strengthened to confirm disease outbreaks and enable a rapid response.“As the relentless conflict renders some areas inaccessible, particularly in the Darfur and Kordofan regions, the population’s health needs continue to increase,” Dr Sahbani said. “To meet these mounting needs and prevent the crisis from spiraling out of hand, WHO and humanitarian partners require safe and unimpeded access to all areas of Sudan, and increased financial resources.”Ultimately, WHO calls parties to the conflict to urgently work towards a ceasefire and peace for the people of Sudan. 

Read full article →
News Cover
ScienceDaily июн 03, 2025

Пребывание на природе может помочь людям с хронической болью в спине справиться со своим состоянием.

Исследователи спросили пациентов, некоторые из которых испытывали боли в пояснице на протяжении 40 лет, помогло ли им пребывание на природе лучше справиться с болью в пояснице. Они обнаружили, что люди, которые могут проводить время в собственных садах, получают некоторую пользу для здоровья и благополучия. Однако те, кто смог погрузиться в большие зеленые пространства, такие как леса, чувствовали себя еще более позитивно, поскольку они могли потеряться в окружающей среде и сосредоточиться больше на этом, чем на уровне боли. Исследователи рекомендовали попытаться включить время, проведенное на природе, в планы лечения людей, а также используют свои результаты для разработки вмешательств в виртуальной реальности, которые позволят людям ощутить некоторые преимущества пребывания на природе без необходимости куда-либо путешествовать, если они не могут это сделать.

Read full article →
News Cover
ScienceDaily июн 03, 2025

Два вида растений изобретают одно и то же химически сложное и интересное с медицинской точки зрения вещество.

Биосинтез огромного разнообразия натуральных растительных продуктов для многих интересных с медицинской точки зрения веществ еще не выяснен. В новом исследовании международная группа исследователей смогла показать, как синтезируются алкалоиды ипекакуаны, вещества, используемые в традиционной медицине. Они сравнили два отдаленно родственных вида растений и смогли показать, что, хотя оба вида растений используют сопоставимый химический подход, ферменты, необходимые для синтеза, различаются, и используется разное исходное вещество. Дальнейшие исследования показали, что пути биосинтеза этих сложных химических соединений развивались независимо у обоих видов. Эти результаты помогают обеспечить синтез этих и родственных веществ в более крупных масштабах для медицинского использования.

Read full article →